0001953988 2025-11-01 2026-04-30 0001953988 2026-06-12 0001953988 2026-04-30 0001953988 2025-10-31 0001953988 HLEO:SeriesAConvertiblePreferredStockMember 2026-04-30 0001953988 HLEO:SeriesAConvertiblePreferredStockMember 2025-10-31 0001953988 HLEO:SeriesBConvertiblePreferredStockMember 2026-04-30 0001953988 HLEO:SeriesBConvertiblePreferredStockMember 2025-10-31 0001953988 HLEO:SeriesDConvertiblePreferredStockMember 2026-04-30 0001953988 HLEO:SeriesDConvertiblePreferredStockMember 2025-10-31 0001953988 2026-02-01 2026-04-30 0001953988 2025-02-01 2025-04-30 0001953988 2024-11-01 2025-04-30 0001953988 us-gaap:ServiceMember 2026-02-01 2026-04-30 0001953988 us-gaap:ServiceMember 2025-02-01 2025-04-30 0001953988 us-gaap:ServiceMember 2025-11-01 2026-04-30 0001953988 us-gaap:ServiceMember 2024-11-01 2025-04-30 0001953988 HLEO:EngineeringFeesMember 2026-02-01 2026-04-30 0001953988 HLEO:EngineeringFeesMember 2025-02-01 2025-04-30 0001953988 HLEO:EngineeringFeesMember 2025-11-01 2026-04-30 0001953988 HLEO:EngineeringFeesMember 2024-11-01 2025-04-30 0001953988 HLEO:MaterialsMember 2026-02-01 2026-04-30 0001953988 HLEO:MaterialsMember 2025-02-01 2025-04-30 0001953988 HLEO:MaterialsMember 2025-11-01 2026-04-30 0001953988 HLEO:MaterialsMember 2024-11-01 2025-04-30 0001953988 HLEO:PreferredStockSeriesBMember 2025-10-31 0001953988 us-gaap:CommonStockMember 2025-10-31 0001953988 HLEO:CommonToBeIssuedStockMember 2025-10-31 0001953988 us-gaap:AdditionalPaidInCapitalMember 2025-10-31 0001953988 us-gaap:RetainedEarningsMember 2025-10-31 0001953988 HLEO:CommonStockToBeIssuedMember 2025-10-31 0001953988 HLEO:PreferredStockSeriesBMember 2026-01-31 0001953988 us-gaap:CommonStockMember 2026-01-31 0001953988 HLEO:CommonToBeIssuedStockMember 2026-01-31 0001953988 us-gaap:AdditionalPaidInCapitalMember 2026-01-31 0001953988 us-gaap:RetainedEarningsMember 2026-01-31 0001953988 2026-01-31 0001953988 HLEO:CommonStockToBeIssuedMember 2026-01-31 0001953988 HLEO:PreferredStockSeriesBMember 2025-11-01 2026-01-31 0001953988 us-gaap:CommonStockMember 2025-11-01 2026-01-31 0001953988 HLEO:CommonToBeIssuedStockMember 2025-11-01 2026-01-31 0001953988 us-gaap:AdditionalPaidInCapitalMember 2025-11-01 2026-01-31 0001953988 us-gaap:RetainedEarningsMember 2025-11-01 2026-01-31 0001953988 2025-11-01 2026-01-31 0001953988 HLEO:PreferredStockSeriesBMember 2026-02-01 2026-04-30 0001953988 us-gaap:CommonStockMember 2026-02-01 2026-04-30 0001953988 HLEO:CommonToBeIssuedStockMember 2026-02-01 2026-04-30 0001953988 us-gaap:AdditionalPaidInCapitalMember 2026-02-01 2026-04-30 0001953988 us-gaap:RetainedEarningsMember 2026-02-01 2026-04-30 0001953988 HLEO:CommonStockToBeIssuedMember 2026-02-01 2026-04-30 0001953988 HLEO:PreferredStockSeriesBMember 2026-04-30 0001953988 us-gaap:CommonStockMember 2026-04-30 0001953988 HLEO:CommonToBeIssuedStockMember 2026-04-30 0001953988 us-gaap:AdditionalPaidInCapitalMember 2026-04-30 0001953988 us-gaap:RetainedEarningsMember 2026-04-30 0001953988 HLEO:CommonStockToBeIssuedMember 2026-04-30 0001953988 2024-10-31 0001953988 2025-04-30 0001953988 us-gaap:CommonStockMember HLEO:HeliospaceMember 2024-01-31 0001953988 us-gaap:CommonStockMember HLEO:HeliospaceMember 2024-01-30 2024-01-31 0001953988 HLEO:NotesPayableMember HLEO:DebtFromUnrelatedPartiesMember 2026-04-30 0001953988 srt:MinimumMember HLEO:NotesPayableMember HLEO:DebtFromUnrelatedPartiesMember 2026-04-30 0001953988 srt:MaximumMember HLEO:NotesPayableMember HLEO:DebtFromUnrelatedPartiesMember 2026-04-30 0001953988 us-gaap:FurnitureAndFixturesMember 2026-04-30 0001953988 us-gaap:FairValueInputsLevel1Member 2026-04-30 0001953988 us-gaap:FairValueInputsLevel2Member 2026-04-30 0001953988 us-gaap:FairValueInputsLevel3Member 2026-04-30 0001953988 us-gaap:FairValueInputsLevel1Member 2025-10-31 0001953988 us-gaap:FairValueInputsLevel2Member 2025-10-31 0001953988 us-gaap:FairValueInputsLevel3Member 2025-10-31 0001953988 us-gaap:StockOptionMember 2025-11-01 2026-04-30 0001953988 us-gaap:StockOptionMember 2024-11-01 2025-04-30 0001953988 us-gaap:ConvertibleNotesPayableMember 2025-11-01 2026-04-30 0001953988 us-gaap:ConvertibleNotesPayableMember 2024-11-01 2025-04-30 0001953988 HLEO:TwoOfficersMember 2026-04-30 0001953988 HLEO:TwoOfficersMember 2025-10-31 0001953988 HLEO:TwoOfficersMember 2025-12-01 2025-12-02 0001953988 HLEO:TwoOfficersMember us-gaap:CommonStockMember 2025-12-01 2025-12-02 0001953988 us-gaap:CommonStockMember HLEO:TwoOfficersMember 2025-12-01 2025-12-02 0001953988 us-gaap:CommonStockMember HLEO:TwoOfficersMember 2025-12-02 0001953988 HLEO:TwoOfficersMember 2025-12-01 2025-12-02 0001953988 srt:ChiefExecutiveOfficerMember 2026-04-21 2026-04-22 0001953988 srt:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2026-04-21 2026-04-22 0001953988 srt:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2026-04-21 2026-04-22 0001953988 srt:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2026-04-22 0001953988 HLEO:ConvertibleNotesMember 2024-03-18 0001953988 HLEO:ConvertibleNotesMember 2024-03-17 2024-03-18 0001953988 HLEO:ConvertibleNotesMember 2026-03-22 2026-03-23 0001953988 HLEO:ConvertibleNotesMember 2026-03-23 0001953988 HLEO:ConvertibleNotesMember 2025-11-01 2026-04-30 0001953988 HLEO:ConvertibleNotesMember 2026-04-30 0001953988 HLEO:IndiciaCapitalLLCMember 2025-04-16 0001953988 HLEO:IndiciaCapitalLLCMember 2025-04-15 2025-04-16 0001953988 HLEO:UnsecuredPromissoryNoteMember 2025-04-15 2025-04-16 0001953988 HLEO:JamesByrdMember 2025-04-16 0001953988 HLEO:UnsecuredPromissoryNoteMember 2026-03-22 2026-03-23 0001953988 HLEO:UnsecuredPromissoryNoteMember 2026-04-30 0001953988 us-gaap:RelatedPartyMember 2026-04-30 0001953988 us-gaap:RelatedPartyMember 2025-10-31 0001953988 HLEO:NotesPayable1Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable1Member 2026-04-30 0001953988 HLEO:NotesPayable1Member 2025-10-31 0001953988 HLEO:NotesPayable2Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable2Member 2026-04-30 0001953988 HLEO:NotesPayable2Member 2025-10-31 0001953988 HLEO:NotesPayable3Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable3Member 2026-04-30 0001953988 HLEO:NotesPayable3Member 2025-10-31 0001953988 HLEO:NotesPayable4Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable4Member 2026-04-30 0001953988 HLEO:NotesPayable4Member 2025-10-31 0001953988 HLEO:NotesPayable5Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable5Member 2026-04-30 0001953988 HLEO:NotesPayable5Member 2025-10-31 0001953988 HLEO:NotesPayable6Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable6Member 2026-04-30 0001953988 HLEO:NotesPayable6Member 2025-10-31 0001953988 HLEO:NotesPayable7Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable7Member 2026-04-30 0001953988 HLEO:NotesPayable7Member 2025-10-31 0001953988 HLEO:NotesPayable8Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable8Member 2026-04-30 0001953988 HLEO:NotesPayable8Member 2025-10-31 0001953988 HLEO:NotesPayable9Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable9Member 2026-04-30 0001953988 HLEO:NotesPayable9Member 2025-10-31 0001953988 HLEO:NotesPayable10Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable10Member 2026-04-30 0001953988 HLEO:NotesPayable10Member 2025-10-31 0001953988 HLEO:NotesPayable11Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable11Member 2026-04-30 0001953988 HLEO:NotesPayable11Member 2025-10-31 0001953988 HLEO:NotesPayable12Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable12Member 2026-04-30 0001953988 HLEO:NotesPayable12Member 2025-10-31 0001953988 HLEO:NotesPayable13Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable13Member 2026-04-30 0001953988 HLEO:NotesPayable13Member 2025-10-31 0001953988 HLEO:NotesPayable14Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable14Member 2026-04-30 0001953988 HLEO:NotesPayable14Member 2025-10-31 0001953988 HLEO:NotesPayable15Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable15Member 2026-04-30 0001953988 HLEO:NotesPayable15Member 2025-10-31 0001953988 HLEO:NotesPayable16Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable16Member 2026-04-30 0001953988 HLEO:NotesPayable16Member 2025-10-31 0001953988 HLEO:NotesPayable17Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable17Member 2026-04-30 0001953988 HLEO:NotesPayable17Member 2025-10-31 0001953988 HLEO:NotesPayable18Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable18Member 2026-04-30 0001953988 HLEO:NotesPayable18Member 2025-10-31 0001953988 HLEO:NotesPayable19Member 2025-11-01 2026-04-30 0001953988 HLEO:NotesPayable19Member 2026-04-30 0001953988 HLEO:NotesPayable19Member 2025-10-31 0001953988 HLEO:NotePayableAgreement2Member 2024-03-12 0001953988 HLEO:NotePayableAgreement2Member 2024-03-11 2024-03-12 0001953988 HLEO:NotePayableAgreement4Member 2024-06-20 0001953988 HLEO:NotePayableAgreement4Member 2024-06-19 2024-06-20 0001953988 HLEO:MaturesOnJune202026Member HLEO:NotePayableAgreement4Member 2024-06-20 0001953988 HLEO:NotePayableAgreement4Member 2024-06-19 2026-06-20 0001953988 HLEO:NotePayableAgreement4Member 2023-11-01 2024-10-31 0001953988 HLEO:NotePayableAgreement4Member 2025-07-01 2025-07-02 0001953988 HLEO:NotePayableAgreement5Member 2024-10-07 0001953988 HLEO:NotePayableAgreement5Member 2026-03-22 2026-03-23 0001953988 HLEO:NotePayableAgreement6Member us-gaap:ConvertibleNotesPayableMember 2024-07-31 0001953988 HLEO:NotePayableAgreement6Member us-gaap:ConvertibleNotesPayableMember 2024-07-30 2024-07-31 0001953988 HLEO:NotePayableAgreement6Member us-gaap:ConvertibleNotesPayableMember 2023-11-01 2024-10-31 0001953988 2025-07-01 2025-07-02 0001953988 2025-07-02 0001953988 HLEO:NotePayableAgreement7Member us-gaap:ConvertibleNotesPayableMember 2024-07-31 0001953988 HLEO:NotePayableAgreement7Member us-gaap:ConvertibleNotesPayableMember 2024-07-30 2024-07-31 0001953988 HLEO:NotePayableAgreement7Member 2024-07-31 0001953988 HLEO:NotePayableAgreement7Member 2023-11-01 2024-10-31 0001953988 HLEO:NotePayableAgreement8Member 2025-01-09 0001953988 HLEO:NotePayableAgreement8Member 2025-01-08 2025-01-09 0001953988 HLEO:NotePayableAgreement9Member 2025-02-03 0001953988 HLEO:NotePayableAgreement9Member 2025-02-02 2025-02-03 0001953988 HLEO:NotePayableAgreement12Member 2025-05-19 0001953988 HLEO:NotePayableAgreement12Member 2025-05-18 2025-05-19 0001953988 HLEO:NotePayableAgreement13Member 2025-06-07 2026-06-08 0001953988 HLEO:NotePayableAgreement13Member 2025-06-07 2025-06-08 0001953988 HLEO:NotePayableAgreement13Member 2025-06-07 2025-06-08 0001953988 HLEO:NotePayableAgreement13Member 2025-06-08 0001953988 HLEO:NotePayableAgreement13Member 2026-04-30 0001953988 HLEO:NotePayableAgreement14Member 2025-09-18 0001953988 HLEO:NotePayableAgreement14Member 2025-09-17 2025-09-18 0001953988 HLEO:NotePayableAgreement14Member 2026-04-30 0001953988 HLEO:NotePayableAgreement15Member 2025-09-30 0001953988 HLEO:NotePayableAgreement15Member 2025-09-29 2025-09-30 0001953988 HLEO:NotePayableAgreement15Member 2026-04-30 0001953988 HLEO:NotePayableAgreement16Member 2025-09-30 0001953988 HLEO:NotePayableAgreement16Member 2025-09-29 2025-09-30 0001953988 HLEO:NotePayableAgreement16Member 2026-04-30 0001953988 HLEO:NotePayableAgreement17Member 2025-09-30 0001953988 HLEO:NotePayableAgreement17Member 2025-09-29 2025-09-30 0001953988 HLEO:NotePayableAgreement17Member 2026-04-30 0001953988 HLEO:NotesPayable19Member 2026-01-23 0001953988 HLEO:ConvertibleSeriesDPreferredStockMember 2026-01-22 2026-04-30 0001953988 HLEO:NotesPayableMember 2026-04-30 0001953988 HLEO:NotePayableAgreementMember us-gaap:ConvertibleNotesPayableMember 2025-08-26 0001953988 HLEO:NotePayableAgreementMember us-gaap:ConvertibleNotesPayableMember 2025-08-25 2025-08-26 0001953988 HLEO:NotePayableAgreementMember us-gaap:ConvertibleNotesPayableMember 2026-02-23 2026-02-24 0001953988 HLEO:NotePayableAgreementMember us-gaap:ConvertibleNotesPayableMember 2026-03-01 2026-03-02 0001953988 HLEO:AccruedInterestMember HLEO:NotePayableAgreementMember us-gaap:ConvertibleNotesPayableMember 2026-03-01 2026-03-02 0001953988 HLEO:NotePayableAgreementMember us-gaap:ConvertibleNotesPayableMember 2026-03-02 0001953988 HLEO:NotePayableAgreementOneMember us-gaap:ConvertibleNotesPayableMember 2025-12-19 0001953988 HLEO:NotePayableAgreementOneMember us-gaap:ConvertibleNotesPayableMember 2025-12-18 2025-12-19 0001953988 HLEO:NotePayableAgreementTwoMember us-gaap:ConvertibleNotesPayableMember 2025-12-19 0001953988 HLEO:NotePayableAgreementTwoMember us-gaap:ConvertibleNotesPayableMember 2025-12-18 2025-12-19 0001953988 HLEO:NotePayableAgreementThreeMember us-gaap:ConvertibleNotesPayableMember 2025-12-19 0001953988 HLEO:NotePayableAgreementThreeMember us-gaap:ConvertibleNotesPayableMember 2025-12-18 2025-12-19 0001953988 HLEO:NotePayableAgreementFourMember us-gaap:ConvertibleNotesPayableMember 2026-01-12 0001953988 HLEO:NotePayableAgreementFourMember us-gaap:ConvertibleNotesPayableMember 2026-01-11 2026-01-12 0001953988 HLEO:NotePayableAgreementFourMember us-gaap:ConvertibleNotesPayableMember 2026-03-04 2026-03-05 0001953988 HLEO:NotePayableAgreementFiveMember us-gaap:ConvertibleNotesPayableMember 2026-01-14 0001953988 HLEO:NotePayableAgreementFiveMember us-gaap:ConvertibleNotesPayableMember 2026-01-13 2026-01-14 0001953988 2026-01-13 2026-01-14 0001953988 2026-01-14 0001953988 HLEO:NotePayableAgreementSixMember us-gaap:ConvertibleNotesPayableMember 2026-02-06 0001953988 HLEO:NotePayableAgreementSixMember us-gaap:ConvertibleNotesPayableMember 2026-02-03 2026-02-06 0001953988 HLEO:NotePayableAgreementSevenMember us-gaap:ConvertibleNotesPayableMember 2026-02-13 0001953988 HLEO:NotePayableAgreementSevenMember us-gaap:ConvertibleNotesPayableMember 2026-02-12 2026-02-13 0001953988 HLEO:NotePayableAgreementEightMember us-gaap:ConvertibleNotesPayableMember 2026-02-17 0001953988 HLEO:NotePayableAgreementEightMember us-gaap:ConvertibleNotesPayableMember 2026-02-16 2026-02-17 0001953988 HLEO:NotePayableAgreementNineMember us-gaap:ConvertibleNotesPayableMember 2026-02-17 0001953988 HLEO:NotePayableAgreementNineMember us-gaap:ConvertibleNotesPayableMember 2026-02-16 2026-02-17 0001953988 us-gaap:ConvertibleNotesPayableMember 2026-04-30 0001953988 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2026-04-30 0001953988 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2025-10-31 0001953988 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2026-02-01 2026-04-30 0001953988 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2025-02-01 2025-04-30 0001953988 HLEO:WarrantDerivativeLiabilityMember 2026-02-01 2026-04-30 0001953988 HLEO:WarrantDerivativeLiabilityMember 2025-02-01 2025-04-30 0001953988 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2025-11-01 2026-04-30 0001953988 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2024-11-01 2025-04-30 0001953988 HLEO:WarrantDerivativeLiabilityMember 2025-11-01 2026-04-30 0001953988 HLEO:WarrantDerivativeLiabilityMember 2024-11-01 2025-04-30 0001953988 srt:MinimumMember us-gaap:MeasurementInputExercisePriceMember 2026-08-26 0001953988 srt:MaximumMember us-gaap:MeasurementInputExercisePriceMember 2026-08-26 0001953988 srt:MinimumMember us-gaap:MeasurementInputExercisePriceMember 2026-04-30 0001953988 srt:MaximumMember us-gaap:MeasurementInputExercisePriceMember 2026-04-30 0001953988 srt:MinimumMember us-gaap:MeasurementInputConversionPriceMember 2026-08-26 0001953988 srt:MaximumMember us-gaap:MeasurementInputConversionPriceMember 2026-08-26 0001953988 srt:MinimumMember us-gaap:MeasurementInputConversionPriceMember 2026-04-30 0001953988 srt:MaximumMember us-gaap:MeasurementInputConversionPriceMember 2026-04-30 0001953988 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2026-08-26 0001953988 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2026-08-26 0001953988 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2026-04-30 0001953988 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2026-04-30 0001953988 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2026-08-26 0001953988 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember 2026-08-26 0001953988 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2026-04-30 0001953988 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember 2026-04-30 0001953988 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-08-26 0001953988 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-08-26 0001953988 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-04-30 0001953988 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-04-30 0001953988 HLEO:UnderlyingPriceOnValuationDateMember HLEO:IncomeApproachValuationTechniqueBlackScholesMember 2026-08-26 0001953988 HLEO:EffectiveContractualConversionRatesMember HLEO:IncomeApproachValuationTechniqueBlackScholesMember 2026-08-26 0001953988 HLEO:ContractualTermToMaturityMember HLEO:IncomeApproachValuationTechniqueBlackScholesMember 2026-08-26 0001953988 HLEO:MarketVolatilityMember HLEO:IncomeApproachValuationTechniqueBlackScholesMember 2026-08-26 0001953988 HLEO:RiskAdjustedInterestRateMember HLEO:IncomeApproachValuationTechniqueBlackScholesMember 2026-08-26 0001953988 HLEO:EquityPlanMember 2026-04-30 0001953988 HLEO:EquityPlanMember 2025-10-31 0001953988 us-gaap:EmployeeStockOptionMember HLEO:EquityPlanMember 2025-11-01 2026-04-30 0001953988 2023-11-01 2024-10-31 0001953988 2024-11-01 2025-01-31 0001953988 2025-01-31 0001953988 2024-11-01 2025-10-31 0001953988 HLEO:RightOfUseLeaseAssetMember 2026-04-30 0001953988 HLEO:RightOfUseLeaseAssetMember 2025-10-31 0001953988 HLEO:OperatingLeaseLiabilityMember 2026-04-30 0001953988 HLEO:OperatingLeaseLiabilityMember 2025-10-31 0001953988 HLEO:FourCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-11-01 2026-04-30 0001953988 HLEO:FourCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-11-01 2025-10-31 0001953988 us-gaap:CustomerConcentrationRiskMember 2026-02-01 2026-04-30 0001953988 us-gaap:CustomerConcentrationRiskMember 2025-02-01 2025-04-30 0001953988 HLEO:GovernmentSourcesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-02-01 2026-04-30 0001953988 HLEO:PrivateCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-02-01 2026-04-30 0001953988 HLEO:GovernmentSourcesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-02-01 2025-04-30 0001953988 HLEO:PrivateCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-02-01 2025-04-30 0001953988 us-gaap:CustomerConcentrationRiskMember 2025-11-01 2026-04-30 0001953988 us-gaap:CustomerConcentrationRiskMember 2024-11-01 2025-04-30 0001953988 HLEO:GovernmentSourcesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-11-01 2026-04-30 0001953988 HLEO:PrivateCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-11-01 2026-04-30 0001953988 HLEO:GovernmentSourcesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-11-01 2025-04-30 0001953988 HLEO:PrivateCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-11-01 2025-04-30 0001953988 HLEO:CustomerAMember HLEO:RevenueMember us-gaap:CustomerConcentrationRiskMember 2025-11-01 2026-04-30 0001953988 HLEO:CustomerAMember HLEO:RevenueMember us-gaap:CustomerConcentrationRiskMember 2024-11-01 2025-10-31 0001953988 HLEO:CustomerBMember HLEO:RevenueMember us-gaap:CustomerConcentrationRiskMember 2025-11-01 2026-04-30 0001953988 HLEO:CustomerBMember HLEO:RevenueMember us-gaap:CustomerConcentrationRiskMember 2024-11-01 2025-10-31 0001953988 HLEO:CustomerCMember HLEO:RevenueMember us-gaap:CustomerConcentrationRiskMember 2025-11-01 2026-04-30 0001953988 HLEO:CustomerCMember HLEO:RevenueMember us-gaap:CustomerConcentrationRiskMember 2024-11-01 2025-10-31 0001953988 HLEO:CustomerDMember HLEO:RevenueMember us-gaap:CustomerConcentrationRiskMember 2025-11-01 2026-04-30 0001953988 HLEO:CustomerDMember HLEO:RevenueMember us-gaap:CustomerConcentrationRiskMember 2024-11-01 2025-10-31 0001953988 HLEO:TotalCustomersMember HLEO:RevenueMember us-gaap:CustomerConcentrationRiskMember 2025-11-01 2026-04-30 0001953988 HLEO:TotalCustomersMember HLEO:RevenueMember us-gaap:CustomerConcentrationRiskMember 2024-11-01 2025-10-31 0001953988 HLEO:BusinessSegmentMember 2025-11-01 2026-04-30 0001953988 HLEO:ConsultantsMember 2026-02-01 2026-04-30 0001953988 srt:ChiefFinancialOfficerMember 2026-02-01 2026-04-30 0001953988 HLEO:DirectorsMember 2026-02-01 2026-04-30 0001953988 srt:ChiefExecutiveOfficerMember 2025-11-01 2026-01-31 0001953988 HLEO:ConsultantsMember 2025-11-01 2026-01-31 0001953988 2026-03-11 2026-03-12 0001953988 2026-03-12 0001953988 us-gaap:SeriesAPreferredStockMember 2026-04-17 0001953988 us-gaap:SeriesAPreferredStockMember 2026-04-16 2026-04-17 0001953988 srt:MinimumMember us-gaap:SeriesAPreferredStockMember 2026-04-16 2026-04-17 0001953988 srt:MaximumMember us-gaap:SeriesAPreferredStockMember 2026-04-16 2026-04-17 0001953988 HLEO:SeriesAConvertiblePreferredStockMember 2026-02-03 2026-02-06 0001953988 HLEO:SeriesAConvertiblePreferredStockMember 2026-02-06 0001953988 HLEO:SeriesDConvertiblePreferredStockMember 2025-11-01 2026-04-30 0001953988 us-gaap:SeriesDPreferredStockMember 2026-04-30 iso4217:USD shares iso4217:USD shares pure HLEO:Integer HLEO:Year false --10-31 2026 Q2 0001953988

P5Y

10-Q true 2026-04-30 false 000-56774 HELIO CORPORATION FL 92-0586004 2448 Sixth Street Berkeley CA 94710 510 545-2666 Yes Yes Non-accelerated Filer true true false false 25944225

464720

7305

394635

489426

81055

102143

940410

598874

53395

64726

72675

76655

399301

566361

525371

707742

1465781

1306616

272911

273936

690455

930555

841613

730500

1737034

488237

197798

621423

39543

455892

477956

3259418

4498435

495000

85000

150000

40185

223319

125185

868319

3384603

5366754

0.0001

1500000

175000 175000

0.0001

500000

177500 177500

0.0001

250000

250000 250000

250000

162964 0 228150 0

100000000

25243454

11371966

8105220

912369

99975

-10352192

-4972507

-1918822

-4060138

1465781

1306616

352428

835656

794023

1595362

42733

94524

57154

249353

62155

242080

101689

755121

457316

1172260

952866

2599836

334709

977895

579572

1994743

122607

194365

373294

605093

418952

742264

3011208

1464917

30626

133678

72518

292244

263164 189285 434274 399796

260014

44081

375291

222819

5666

11332

978422

1114974

3904623

2391108

-855815

-920609

-3531329

-1786015

74744

94424

239053

148160

383342

-0

444575

-0

-130150

-318942

89237

51480 -0 51480 -0

239663

-0

883543

-0

-790142

-94424

-1848356

-148160

-1645957

-1015033

-5379685

-1934175

-0.07

-0.09

-0.26

-0.17

23758674

11263633

20858117

11263633

11371966

912369

-4972507

-4060138

32384

4262000

2131600

7398459

1701646

150000 41517 41517

-3733728

23182425

4819516

-8706235

-3886719

26997

879163 879163 863536 946500 946500 0 162964 228150 228150

571000

274932

127712

279689

149979 427440 427440 263198

391437

52604 8066 8066 33000 51480 51480

250000

99975

100000

-1645957

250000

25243454

8105220

162964

228150

99975

-10352192

-1918822

-5379685

-1934175

11331

11332

59381

87754

2406532

883543

51480 0

89237

-0

444575

167060

200038

-318942

-0

-94791

-381349

-21088

13102

-0 -174537

3980

132077

100235

-240100

-33125

-205198

-201165

-1319440

-1226322

1174650

100000

150000

213119

545000

1190866

457034

-0

420263

-0

32549 4531

8066

1776855

690469

457415

-535853

7305

551552

464720

15699

161274

82024

2408775 0 100000 0 41517 0 220500 0 743612 0 785131 0 391437 0 879163 0

NOTE 1: BUSINESS Helio Corporation (the “Company” or “Helio”) is an aerospace technology, engineering, and research and development (R&D) holding company serving commercial, government, and non-profit organizations. Heliospace Corporation (“Heliospace”), the Company’s wholly-owned subsidiary, is an aerospace company specializing in the design, engineering, assembly and test of space flight qualified hardware, providing systems engineering, modeling, analysis, integration and test services for space missions. Heliospace was incorporated on March 6, 2018 in Delaware. The Company’s products include aerospace related hardware, systems, and services for customers such as NASA, universities, and private space companies. The customer base ranges from NASA and foreign space agencies to private companies, foundations, universities, and non-profits. Heliospace designs, fabricates, assembles and tests space qualified hardware, including radar antennas for the NASA Europa Clipper mission, antennas for the SunRISE CubeSat constellation, and deployable systems and sensors for numerous lunar landers and the Mars Sample Return program. Heliospace also provides systems engineering, integration and test, and mission formulation services, including support for the design, testing, and launch of the James Webb Space Telescope, formulation and design of the Roman Space Telescope, Habworlds Observatory, Mars Sample Return, and the Atmospheric Observing System. Our support of science and technology missions is currently well established with our hardware and service lines; we are now expanding these offerings into larger integrated solutions in the form of Space Based Solar Power, pursuing large addressable markets which we believe have significant revenue growth potential. Change-in-control Transaction On October 3, 2022, Helio was incorporated in Florida, under the name Stirling Bridge Group, Inc. In May of 2023, the Company changed its name to Web3 Corporation. In January 2024, the Company acquired <span id="xdx_908_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_c20240131__us-gaap--BusinessAcquisitionAxis__custom--HeliospaceMember__us-gaap--AwardTypeAxis__us-gaap--CommonStockMember_zwk74wlzRQCl" title="Interest acquired">100% of Heliospace’s common stock shares in exchange for <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240130__20240131__us-gaap--BusinessAcquisitionAxis__custom--HeliospaceMember__us-gaap--AwardTypeAxis__us-gaap--CommonStockMember_z7YyvRs7bkU8" title="Newly issued shares">9,795,733 newly issued shares of common stock of the Company (the “Share Exchange”), and changed its name from Web3 Corporation to the Helio Corporation. The Company’s principal executive offices are located at 2448 Sixth Street, Berkeley, CA 94710. The transaction was accounted for as a recapitalization of Heliospace as Heliospace was deemed the accounting acquirer. The historical financial statements are that of Heliospace; therefore the pre-transaction financial statements are that of Heliospace. The transaction was effective on January 4, 2024 and combines the financial statements from the transaction date forward. Liquidity During the year ended October 31, 2025 and the six months ended April 30, 2026, the Company entered into additional debt and equity financings to obtain additional funding (see Note 5, 6 and 13). Additional financing or capital investment will be necessary to sustain operations for one year from the issuance of these condensed consolidated financial statements. During the year ended October 31, 2025 and the six months ended April 30, 2026, the Company entered into additional note payable agreements and convertible note agreements to obtain additional funding (see Note 5 and 6). Additional financing or capital investment will be necessary to sustain operations for one year from the issuance of these condensed consolidated financial statements. The Company is currently engaged in negotiations with prospective lenders regarding potential bridge financing arrangements, and potential investors for the purchase of convertible notes or equity investments. These discussions are ongoing, and there can be no assurance that the Company will enter into definitive agreements or that any such financing will be completed on favorable terms or at all. If completed, the Company expects to use the net proceeds from investments and bridge financing to repay certain outstanding promissory notes and to support key operational initiatives. These include investments in research and development, expansion of sales, marketing, and business development activities, facility and infrastructure enhancements, manufacturing improvements, and other general corporate purposes, including working capital and upgrades to the Company’s financial and contract management systems. The Company will need to raise substantial additional capital to accomplish its business plan for the foreseeable future. There can be no assurance as to the availability, if any, or terms upon which such financing and capital might be available in the future. As of April 30, 2026, the Company has outstanding debt from unrelated parties pursuant to notes payable in the aggregate principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20260430__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DebtFromUnrelatedPartiesMember_zGx3acrjgxXg" title="Face amount">815,500 and convertible notes payable in the amount of $<span id="xdx_90B_eus-gaap--ConvertibleNotesPayable_iI_c20260430__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DebtFromUnrelatedPartiesMember_zi4YnCek6J19" title="Convertible notes payable">1,032,692. The remaining notes bear interest ranging from <span id="xdx_90F_eus-gaap--LongTermDebtPercentageBearingFixedInterestRate_iI_c20260430__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember__srt--RangeAxis__srt--MinimumMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DebtFromUnrelatedPartiesMember_zgS5XkUNmqx9" title="Interest rate">9.75% and <span id="xdx_901_eus-gaap--LongTermDebtPercentageBearingFixedInterestRate_iI_dp_c20260430__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember__srt--RangeAxis__srt--MaximumMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DebtFromUnrelatedPartiesMember_znIKYovEZ5ue" title="Interest rate">12.00% and mature within the next two fiscal years. Certain of these notes were initially convertible but were amended to eliminate the conversion features in consideration of the issuance by the Company and/or the transfer by certain shareholders of shares of the Company’s common stock (See Note 5). Interest on these notes either accrues or is paid quarterly or at maturity along with principal, as specifically described in the note. Upon the occurrence and during the continuance of any default by the Company under any of the above notes, which default is not cured within fifteen (15) days following written notice of such default from the payee, the payee may declare the entire unpaid principal and unpaid interest immediately due and payable. Certain of these notes are secured by the Company’s accounts receivable, and by shares of common stock pledged by one of the Company’s shareholders. In addition, certain of these notes become due, and the payees under certain of these notes have the right to accelerate their notes, upon the completion of an offering. Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company’s ability to continue as a going concern for one year from the issuance of the condensed consolidated financial statements. The condensed consolidated financial statements have been prepared under the going concern basis of accounting. These condensed consolidated financial statements do not include any adjustments that might be necessary from the outcome of this uncertainty.

2022-10-03

9795733

815500

1032692

9.75

0.1200

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to U.S. generally accepted accounting principles (“U.S. GAAP) and reflect all adjustments which are, in the opinion of management, necessary to a fair presentation of the results of the interim periods presented, under the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). These condensed consolidated financial statements include all adjustments consisting of only normal recurring adjustments, necessary for a fair statement of the results of the interim periods presented. The condensed consolidated financial statements include the accounts of Helio Corporation and its wholly-owned subsidiary Heliospace. The Company’s condensed consolidated financial statements reflect the elimination of all significant inter-company accounts and transactions. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for any subsequent quarter or for the entire year ending October 31, 2026. Certain information and note disclosures normally included in the Company’s annual audited consolidated financial statements and accompanying notes prepared in accordance with U.S. GAAP have been condensed in, or omitted from, these interim financial statements. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes to the consolidated financial statements for the fiscal year ended October 31, 2025 included in the Company’s financial statements as part of the Company’s 10K filed on February 17, 2026. Reclassification Certain reclassifications have been made to prior periods for comparative presentation purposes only. Cash and Cash Equivalents For the purposes of the condensed consolidated statements of cash flows, the Company considers all highly liquid investments purchased with a maturity of three (3) months or less to be cash equivalents. The Company has no cash equivalents as of April 30, 2026 and October 31, 2025. Cash accounts are insured at the Federal Deposit Insurance Corporation limits of $250,000 per bank. At times throughout the year, such bank balances may have exceeded the federally insured limit. As of April 30, 2026, there were $164,299 in bank balances in excess of the federally insured limit. Work In Progress Work In Progress (WIP) tracks the costs incurred of a specific job that has not reached a certain milestone achievement. This is the computed value of work performed to advance milestone(s) that have not yet been billed and is used to track total job cost (billed and unbilled). Revenue of WIP is only recognized for specific milestones that are distinct contractual performance obligations that provide identifiable benefits to the customer independently of other project phases. Accounts Receivable, net Accounts receivables are recorded at the amount the Company expects to collect on the balance outstanding at period-end. Management closely monitors outstanding balances during the year and allocates an allowance account if appropriate. The Company estimates and records a credit loss expense related to its financial instruments, including its accounts receivables. The Company considers historical collection rates, the current financial status of its customers, macroeconomic factors, and other industry-specific factors when evaluating for current expected credit losses. Forward-looking information is also considered in the evaluation of current expected credit losses. However, because of the short time to the expected receipt of accounts receivable, the Company believes that the carrying value, net of expected losses, approximates fair value and therefore, relies more on historical and current analysis of such financial instruments. Based on this analysis, the Company has determined that no allowance for credit losses is necessary for the current or prior reporting periods. As of April 30, 2026 and October 31, 2025, there was no amount recorded relating to the allowance for credit losses. The Company writes off bad debts as they occur during the year, if applicable. During the three and six months ended April 30, 2026 and 2025, there was no bad debt expense recorded. Accounts receivable as of April 30, 2026 and October 31, 2025 was $394,635 and $489,426, respectively. Property and Equipment, net Property and equipment is stated at cost. Depreciation is computed primarily using the straight-line method over the estimated useful lives of the assets. Expenditures for repairs and maintenance are charged to expense as incurred. For assets sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in the condensed consolidated statements of operations during the period in which the disposal occurred. The Company computes depreciation utilizing estimated useful lives, as stated below: <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfDepreciationUtilizingEstimatedUsefulLivesTableTextBlock_znLYMjY4zzlc" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Estimated useful lives)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of estimated useful lives</td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 81%; text-align: justify">Property and Equipment, net Categories</td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 18%; text-align: center">Estimated Useful Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Furniture and equipment</td> <td> </td> <td style="text-align: center"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20260430__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z78jYhcjEBA2" title="Estimated Useful Life">10 Years</td></tr> </table> Management regularly reviews property and equipment for possible impairment. This review occurs annually or more frequently if events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. Based on management’s assessment, there were no indicators of impairment of the Company’s property and equipment as of April 30, 2026 or October 31, 2025, respectively. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, if any at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates. Fair Value Measurements Accounting Standards Codification (“ASC”) 820 Fair Value Measurements defines fair value, establishes a framework for measuring fair value in GAAP and expands disclosure about fair value measurements. The following provides an analysis of financial instruments that are measured subsequent to initial recognition at fair value, grouped into Levels 1 to 3 based on the degree to which fair value is observable: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"> </td> <td style="width: 62px; text-align: justify">Level 1 — </td> <td style="text-align: justify">fair value measurements are those derived from quoted prices (unadjusted in active markets for identical assets or liabilities);</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">Level 2 —</td> <td style="text-align: justify">fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">Level 3 —</td> <td style="text-align: justify">fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data (unobservable inputs).</td></tr> </table> Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management for the respective periods. The respective carrying value of certain financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash, short-term notes payable, accounts payable and accrued expenses. The carrying value of long-term debt approximates fair value, as the fixed interest rates approximate current market rates. The following table represents the Company’s assets and liabilities by level measured at fair value on a recurring basis at April 30, 2026 and October 31, 2025. <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zhuAXJIKaEci" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Schedule of fair value measurements</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 28%; text-align: left">Embedded derivative liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--EmbeddedDerivativeLiability_iI_d0_c20260430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zV90q7RPvVhk" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--EmbeddedDerivativeLiability_iI_d0_c20260430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlvaa3spQGB" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--EmbeddedDerivativeLiability_iI_c20260430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zxaAgoOqyyD8" style="width: 8%; text-align: right" title="Embedded derivative liabilities">621,423</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--EmbeddedDerivativeLiability_iI_d0_c20251031__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zOnw27tcaPkh" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--EmbeddedDerivativeLiability_iI_d0_c20251031__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zA1ezPEV0AM4" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--EmbeddedDerivativeLiability_iI_c20251031__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkKTGhqiR9Dh" style="width: 8%; text-align: right" title="Embedded derivative liabilities">39,543</td><td style="width: 1%; text-align: left"> </td></tr> </table> Revenue Recognition The Company records revenue based on a five-step model in accordance with the Financial Accounting Standards Board (“FASB”) ASC 606, Revenue from Contracts with Customers, which requires the following: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">1.</td> <td style="text-align: justify">Identify the contract with a customer.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">2.</td> <td style="text-align: justify">Identify the performance obligations in the contract.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">3.</td> <td style="text-align: justify">Determine the transaction price of the contract.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">4.</td> <td style="text-align: justify">Allocate the transaction price to the performance obligations in the contract.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">5.</td> <td style="text-align: justify">Recognize revenue when the performance obligations are met or delivered.</td></tr> </table> The Company’s operating revenues are primarily generated from service fees, engineering fees, and materials fees. The Company uses two different types of contracts which are deliverable based or time based. The Company recognizes revenue related to services when performance obligations are fulfilled. Design service contracts deliver system engineering inputs including designs, analyses, test and verification plans, and mission formulation architectures on a continual basis over the course of a contract. Customer work is based on distinct identifiable contracts with clear performance obligations, objectives, and pricing. Service revenue contract types are either Time & Materials (T&M) or Purchase Order (PO) contracts. Time & Materials contracts meet performance obligations continuously and are billed with revenue recognized at each invoice. PO contracts are billed at fulfillment of a performance obligation based on the customer agreements, and thus revenue is recognized when the performance obligations are satisfied. Engineering services deliver both space qualified hardware and accompanying analyses, and are conducted under Cost-type, Fixed price, PO, and T&M contracts. Cost-type and T&M Engineering contracts are billed monthly as work is completed and revenue is recognized. Revenue for fixed price contracts including purchase orders that specify priced milestones for delivery of hardware, reports, or analyses is recognized upon completion of a specific milestone. Revenue on fixed price contracts that are still in progress at month end are otherwise recognized on the percentage-of-completion method, measured by the percentage of total costs incurred to date to the estimated total costs for each contract. Income Taxes The Company accounts for income taxes under the provisions of ASC 740 Accounting for Income Taxes, which requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more likely than not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. Deferred income taxes are recognized for the tax consequences related to temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for tax purposes at each year end, based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Deferred income taxes are also recognized for carry-forward losses which can be utilized to offset future taxable income. A valuation allowance is recognized when, based on the weight of all available evidence, it is considered more likely than not that all, or some portion, of the net deferred tax assets will not be realized. The Company evaluates its valuation allowance requirements based on projected future operations. When circumstances change and cause a change in management’s judgment about the recoverability of deferred tax assets, the impact of the change on the valuation is reflected in current income. Income tax expense is comprised of the sum of current income tax plus the change in deferred tax assets and liabilities. Earnings (loss) Per Share Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of outstanding common shares, plus the net impact of common shares (computed using the treasury stock method), if dilutive, resulting from the exercise of dilutive securities. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. As of April 30, 2026 and 2025, the Company excluded the common stock equivalents summarized below, which entitle the holders thereof to ultimately acquire shares of common stock, from its calculation of earnings (loss) per share, as their effect would have been anti-dilutive. <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLVTrP2hzQK5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of antidilutive securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt; width: 66%">Stock options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20251101__20260430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zKLAXoegrnjj" style="width: 13%; text-align: right" title="Anti-dilutive shares">1,615,129</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20241101__20250430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_z36as9SDJ6c2" style="width: 13%; text-align: right" title="Anti-dilutive shares">1,422,307</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Convertible notes payable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20251101__20260430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zPle5jlPWEhd" style="border-bottom: Black 1pt solid; text-align: right" title="Anti-dilutive shares">5,188,200</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20241101__20250430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zRxcM8D9AEul" style="border-bottom: Black 1pt solid; text-align: right" title="Anti-dilutive shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total common stock equivalents</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20251101__20260430_zaPFpDOPUmL8" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive shares">6,803,329</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20241101__20250430_zD4V7x2B6Yfj" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive shares">1,422,307</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Leases The Company accounts for leases based on ASC Topic 842, Leases. Based on this standard, the Company determines if an agreement is a lease at inception. Operating leases are included in right-of-use lease asset, current operating lease obligations, and operating lease obligations, in the Company’s condensed consolidated balance sheets. As permitted under Accounting Standards Updated (“ASU”) 2016-02 Leases (Topic 842) the Company has made an accounting policy election not to apply the recognition provisions of ASU 2016-02 to short term leases (leases with a lease term 12 months or less that do not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis over the lease term. Research and Development Research and development costs are expensed as incurred. These costs include, but are not limited to, employee related expenses, including salaries, benefits and stock-based compensation of research and development personnel, supplies, facilities, depreciation and other expenses, which include direct and allocated expenses for rent, utilities and insurance. During the six months ended April 30, 2026 and 2025, the company recorded $11,120 and $168,351 in research and development costs, respectively. During the three months ended April 30, 2026 and 2025, the company recorded $670 and $110,607 in research and development costs, respectively. Research and development costs are categorized in the general and administrative expense section of the condensed consolidated statements of operations. Stock based-Based Compensation The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718, Stock Compensation. The computation of the expense associated with stock-based compensation requires the use of a valuations model. The Company currently obtains valuation reports according to FASB ASC Topic 718 — Stock Compensation (“ASC 718”). Equity-based compensation consists solely of stock option awards, including Incentivized Stock Options (ISOs) and Non-Qualified Stock Options (NSOs). Compensation expense is recognized ratably over the vesting period as the employee provides services. See Note 8 – Stock Options for additional information. Recently Issued Accounting Pronouncements The Company does not believe that there are any new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to U.S. generally accepted accounting principles (“U.S. GAAP) and reflect all adjustments which are, in the opinion of management, necessary to a fair presentation of the results of the interim periods presented, under the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). These condensed consolidated financial statements include all adjustments consisting of only normal recurring adjustments, necessary for a fair statement of the results of the interim periods presented. The condensed consolidated financial statements include the accounts of Helio Corporation and its wholly-owned subsidiary Heliospace. The Company’s condensed consolidated financial statements reflect the elimination of all significant inter-company accounts and transactions. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for any subsequent quarter or for the entire year ending October 31, 2026. Certain information and note disclosures normally included in the Company’s annual audited consolidated financial statements and accompanying notes prepared in accordance with U.S. GAAP have been condensed in, or omitted from, these interim financial statements. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes to the consolidated financial statements for the fiscal year ended October 31, 2025 included in the Company’s financial statements as part of the Company’s 10K filed on February 17, 2026.

Reclassification Certain reclassifications have been made to prior periods for comparative presentation purposes only.

Cash and Cash Equivalents For the purposes of the condensed consolidated statements of cash flows, the Company considers all highly liquid investments purchased with a maturity of three (3) months or less to be cash equivalents. The Company has no cash equivalents as of April 30, 2026 and October 31, 2025. Cash accounts are insured at the Federal Deposit Insurance Corporation limits of $250,000 per bank. At times throughout the year, such bank balances may have exceeded the federally insured limit. As of April 30, 2026, there were $164,299 in bank balances in excess of the federally insured limit.

250000

164299

Work In Progress Work In Progress (WIP) tracks the costs incurred of a specific job that has not reached a certain milestone achievement. This is the computed value of work performed to advance milestone(s) that have not yet been billed and is used to track total job cost (billed and unbilled). Revenue of WIP is only recognized for specific milestones that are distinct contractual performance obligations that provide identifiable benefits to the customer independently of other project phases.

Accounts Receivable, net Accounts receivables are recorded at the amount the Company expects to collect on the balance outstanding at period-end. Management closely monitors outstanding balances during the year and allocates an allowance account if appropriate. The Company estimates and records a credit loss expense related to its financial instruments, including its accounts receivables. The Company considers historical collection rates, the current financial status of its customers, macroeconomic factors, and other industry-specific factors when evaluating for current expected credit losses. Forward-looking information is also considered in the evaluation of current expected credit losses. However, because of the short time to the expected receipt of accounts receivable, the Company believes that the carrying value, net of expected losses, approximates fair value and therefore, relies more on historical and current analysis of such financial instruments. Based on this analysis, the Company has determined that no allowance for credit losses is necessary for the current or prior reporting periods. As of April 30, 2026 and October 31, 2025, there was no amount recorded relating to the allowance for credit losses. The Company writes off bad debts as they occur during the year, if applicable. During the three and six months ended April 30, 2026 and 2025, there was no bad debt expense recorded. Accounts receivable as of April 30, 2026 and October 31, 2025 was $394,635 and $489,426, respectively.

394635

489426

Property and Equipment, net Property and equipment is stated at cost. Depreciation is computed primarily using the straight-line method over the estimated useful lives of the assets. Expenditures for repairs and maintenance are charged to expense as incurred. For assets sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in the condensed consolidated statements of operations during the period in which the disposal occurred. The Company computes depreciation utilizing estimated useful lives, as stated below: <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfDepreciationUtilizingEstimatedUsefulLivesTableTextBlock_znLYMjY4zzlc" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Estimated useful lives)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of estimated useful lives</td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 81%; text-align: justify">Property and Equipment, net Categories</td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 18%; text-align: center">Estimated Useful Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Furniture and equipment</td> <td> </td> <td style="text-align: center"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20260430__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z78jYhcjEBA2" title="Estimated Useful Life">10 Years</td></tr> </table> Management regularly reviews property and equipment for possible impairment. This review occurs annually or more frequently if events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. Based on management’s assessment, there were no indicators of impairment of the Company’s property and equipment as of April 30, 2026 or October 31, 2025, respectively.

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfDepreciationUtilizingEstimatedUsefulLivesTableTextBlock_znLYMjY4zzlc" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Estimated useful lives)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of estimated useful lives</td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 81%; text-align: justify">Property and Equipment, net Categories</td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 18%; text-align: center">Estimated Useful Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Furniture and equipment</td> <td> </td> <td style="text-align: center"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20260430__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z78jYhcjEBA2" title="Estimated Useful Life">10 Years</td></tr> </table>

P10Y

Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, if any at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates.

Fair Value Measurements Accounting Standards Codification (“ASC”) 820 Fair Value Measurements defines fair value, establishes a framework for measuring fair value in GAAP and expands disclosure about fair value measurements. The following provides an analysis of financial instruments that are measured subsequent to initial recognition at fair value, grouped into Levels 1 to 3 based on the degree to which fair value is observable: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"> </td> <td style="width: 62px; text-align: justify">Level 1 — </td> <td style="text-align: justify">fair value measurements are those derived from quoted prices (unadjusted in active markets for identical assets or liabilities);</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">Level 2 —</td> <td style="text-align: justify">fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">Level 3 —</td> <td style="text-align: justify">fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data (unobservable inputs).</td></tr> </table> Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management for the respective periods. The respective carrying value of certain financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash, short-term notes payable, accounts payable and accrued expenses. The carrying value of long-term debt approximates fair value, as the fixed interest rates approximate current market rates. The following table represents the Company’s assets and liabilities by level measured at fair value on a recurring basis at April 30, 2026 and October 31, 2025. <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zhuAXJIKaEci" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Schedule of fair value measurements</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 28%; text-align: left">Embedded derivative liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--EmbeddedDerivativeLiability_iI_d0_c20260430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zV90q7RPvVhk" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--EmbeddedDerivativeLiability_iI_d0_c20260430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlvaa3spQGB" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--EmbeddedDerivativeLiability_iI_c20260430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zxaAgoOqyyD8" style="width: 8%; text-align: right" title="Embedded derivative liabilities">621,423</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--EmbeddedDerivativeLiability_iI_d0_c20251031__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zOnw27tcaPkh" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--EmbeddedDerivativeLiability_iI_d0_c20251031__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zA1ezPEV0AM4" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--EmbeddedDerivativeLiability_iI_c20251031__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkKTGhqiR9Dh" style="width: 8%; text-align: right" title="Embedded derivative liabilities">39,543</td><td style="width: 1%; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zhuAXJIKaEci" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Schedule of fair value measurements</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 28%; text-align: left">Embedded derivative liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--EmbeddedDerivativeLiability_iI_d0_c20260430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zV90q7RPvVhk" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--EmbeddedDerivativeLiability_iI_d0_c20260430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlvaa3spQGB" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--EmbeddedDerivativeLiability_iI_c20260430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zxaAgoOqyyD8" style="width: 8%; text-align: right" title="Embedded derivative liabilities">621,423</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--EmbeddedDerivativeLiability_iI_d0_c20251031__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zOnw27tcaPkh" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--EmbeddedDerivativeLiability_iI_d0_c20251031__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zA1ezPEV0AM4" style="width: 8%; text-align: right" title="Embedded derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--EmbeddedDerivativeLiability_iI_c20251031__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkKTGhqiR9Dh" style="width: 8%; text-align: right" title="Embedded derivative liabilities">39,543</td><td style="width: 1%; text-align: left"> </td></tr> </table>

0 0 621423 0 0 39543

Revenue Recognition The Company records revenue based on a five-step model in accordance with the Financial Accounting Standards Board (“FASB”) ASC 606, Revenue from Contracts with Customers, which requires the following: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">1.</td> <td style="text-align: justify">Identify the contract with a customer.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">2.</td> <td style="text-align: justify">Identify the performance obligations in the contract.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">3.</td> <td style="text-align: justify">Determine the transaction price of the contract.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">4.</td> <td style="text-align: justify">Allocate the transaction price to the performance obligations in the contract.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">5.</td> <td style="text-align: justify">Recognize revenue when the performance obligations are met or delivered.</td></tr> </table> The Company’s operating revenues are primarily generated from service fees, engineering fees, and materials fees. The Company uses two different types of contracts which are deliverable based or time based. The Company recognizes revenue related to services when performance obligations are fulfilled. Design service contracts deliver system engineering inputs including designs, analyses, test and verification plans, and mission formulation architectures on a continual basis over the course of a contract. Customer work is based on distinct identifiable contracts with clear performance obligations, objectives, and pricing. Service revenue contract types are either Time & Materials (T&M) or Purchase Order (PO) contracts. Time & Materials contracts meet performance obligations continuously and are billed with revenue recognized at each invoice. PO contracts are billed at fulfillment of a performance obligation based on the customer agreements, and thus revenue is recognized when the performance obligations are satisfied. Engineering services deliver both space qualified hardware and accompanying analyses, and are conducted under Cost-type, Fixed price, PO, and T&M contracts. Cost-type and T&M Engineering contracts are billed monthly as work is completed and revenue is recognized. Revenue for fixed price contracts including purchase orders that specify priced milestones for delivery of hardware, reports, or analyses is recognized upon completion of a specific milestone. Revenue on fixed price contracts that are still in progress at month end are otherwise recognized on the percentage-of-completion method, measured by the percentage of total costs incurred to date to the estimated total costs for each contract.

Income Taxes The Company accounts for income taxes under the provisions of ASC 740 Accounting for Income Taxes, which requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more likely than not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. Deferred income taxes are recognized for the tax consequences related to temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for tax purposes at each year end, based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Deferred income taxes are also recognized for carry-forward losses which can be utilized to offset future taxable income. A valuation allowance is recognized when, based on the weight of all available evidence, it is considered more likely than not that all, or some portion, of the net deferred tax assets will not be realized. The Company evaluates its valuation allowance requirements based on projected future operations. When circumstances change and cause a change in management’s judgment about the recoverability of deferred tax assets, the impact of the change on the valuation is reflected in current income. Income tax expense is comprised of the sum of current income tax plus the change in deferred tax assets and liabilities.

Earnings (loss) Per Share Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of outstanding common shares, plus the net impact of common shares (computed using the treasury stock method), if dilutive, resulting from the exercise of dilutive securities. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. As of April 30, 2026 and 2025, the Company excluded the common stock equivalents summarized below, which entitle the holders thereof to ultimately acquire shares of common stock, from its calculation of earnings (loss) per share, as their effect would have been anti-dilutive. <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLVTrP2hzQK5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of antidilutive securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt; width: 66%">Stock options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20251101__20260430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zKLAXoegrnjj" style="width: 13%; text-align: right" title="Anti-dilutive shares">1,615,129</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20241101__20250430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_z36as9SDJ6c2" style="width: 13%; text-align: right" title="Anti-dilutive shares">1,422,307</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Convertible notes payable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20251101__20260430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zPle5jlPWEhd" style="border-bottom: Black 1pt solid; text-align: right" title="Anti-dilutive shares">5,188,200</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20241101__20250430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zRxcM8D9AEul" style="border-bottom: Black 1pt solid; text-align: right" title="Anti-dilutive shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total common stock equivalents</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20251101__20260430_zaPFpDOPUmL8" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive shares">6,803,329</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20241101__20250430_zD4V7x2B6Yfj" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive shares">1,422,307</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLVTrP2hzQK5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of antidilutive securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt; width: 66%">Stock options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20251101__20260430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zKLAXoegrnjj" style="width: 13%; text-align: right" title="Anti-dilutive shares">1,615,129</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20241101__20250430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_z36as9SDJ6c2" style="width: 13%; text-align: right" title="Anti-dilutive shares">1,422,307</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Convertible notes payable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20251101__20260430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zPle5jlPWEhd" style="border-bottom: Black 1pt solid; text-align: right" title="Anti-dilutive shares">5,188,200</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20241101__20250430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zRxcM8D9AEul" style="border-bottom: Black 1pt solid; text-align: right" title="Anti-dilutive shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total common stock equivalents</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20251101__20260430_zaPFpDOPUmL8" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive shares">6,803,329</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20241101__20250430_zD4V7x2B6Yfj" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive shares">1,422,307</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1615129

1422307

5188200

6803329

1422307

Leases The Company accounts for leases based on ASC Topic 842, Leases. Based on this standard, the Company determines if an agreement is a lease at inception. Operating leases are included in right-of-use lease asset, current operating lease obligations, and operating lease obligations, in the Company’s condensed consolidated balance sheets. As permitted under Accounting Standards Updated (“ASU”) 2016-02 Leases (Topic 842) the Company has made an accounting policy election not to apply the recognition provisions of ASU 2016-02 to short term leases (leases with a lease term 12 months or less that do not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis over the lease term.

P12M

Research and Development Research and development costs are expensed as incurred. These costs include, but are not limited to, employee related expenses, including salaries, benefits and stock-based compensation of research and development personnel, supplies, facilities, depreciation and other expenses, which include direct and allocated expenses for rent, utilities and insurance. During the six months ended April 30, 2026 and 2025, the company recorded $11,120 and $168,351 in research and development costs, respectively. During the three months ended April 30, 2026 and 2025, the company recorded $670 and $110,607 in research and development costs, respectively. Research and development costs are categorized in the general and administrative expense section of the condensed consolidated statements of operations.

11120

168351

670

110607

Stock based-Based Compensation The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718, Stock Compensation. The computation of the expense associated with stock-based compensation requires the use of a valuations model. The Company currently obtains valuation reports according to FASB ASC Topic 718 — Stock Compensation (“ASC 718”). Equity-based compensation consists solely of stock option awards, including Incentivized Stock Options (ISOs) and Non-Qualified Stock Options (NSOs). Compensation expense is recognized ratably over the vesting period as the employee provides services. See Note 8 – Stock Options for additional information.

Recently Issued Accounting Pronouncements The Company does not believe that there are any new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE 3: PROPERTY AND EQUIPMENT The major classifications of property and equipment are summarized as follows: <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGUul4ZTk51b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details - Property and equipment)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Schedule of property and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20260430_zSfuuN0lqOGa" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20251031_zodRbDhGu356" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_z5aQtl5WSbi5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Furniture and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">465,091</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">465,091</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zhfsyQ2VtqY6" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(411,696</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(400,365</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iI_zC46WVmbramd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">53,395</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">64,726</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Depreciation expense for each of the six months ended April 30, 2026 and 2025 was $11,332. Depreciation expense for each of the three months ended April 30, 2026 and 2025 was $5,666.

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGUul4ZTk51b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details - Property and equipment)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Schedule of property and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20260430_zSfuuN0lqOGa" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20251031_zodRbDhGu356" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_z5aQtl5WSbi5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Furniture and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">465,091</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">465,091</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zhfsyQ2VtqY6" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(411,696</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(400,365</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iI_zC46WVmbramd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">53,395</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">64,726</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

465091

411696

400365

53395

64726

11332

5666

NOTE 4: NOTES PAYABLE – RELATED PARTIES Between April 2022 and September 2025, certain related parties, including the Company’s Chief Executive Officer and Director and its Chief Engineer and Director, made various loans to the Company. The balance at April 30, 2026 and October 31, 2025 was $0 and $1,336,613, respectively. These notes were collateralized with the Company’s accounts receivables and other assets. On December 2, 2025, the Company entered into exchange agreements with the Company’s then Chief Executive Officer and Chairman of the Board, and the Company’s Chief Engineer and a member of the Board of Directors. Pursuant to the Exchange Agreement, the officers exchanged principal in the amount of $<span id="xdx_906_eus-gaap--DebtConversionOriginalDebtAmount1_c20251201__20251202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoOfficersMember_zZ60yxbeaege" title="Investment principal amount">969,054 and $88,712 in accrued interest for <span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251201__20251202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoOfficersMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zAWjsS520Mc7" title="Conversion of notes payable-related parties and accrued interest, shares">7,398,459 shares of the Company’s common stock. The shares were valued at $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20251201__20251202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoOfficersMember__us-gaap--AwardTypeAxis__us-gaap--CommonStockMember_zuJuqPXh5bJ5" title="Conversion of notes payable-related parties and accrued interest">1,701,646, or $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20251202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoOfficersMember__us-gaap--AwardTypeAxis__us-gaap--CommonStockMember_zKBireC46uKd" title="Shares issued per share">0.23 per share. This resulted in a loss on debt extinguishment in the amount of $643,880. On April 22, 2026, the Company entered into exchange agreements with the Company’s then Chief Executive Officer and Chairman of the Board. Pursuant to the Exchange Agreement, the officer exchanged principal in the amount of $327,629 for <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20260421__20260422__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkppOl1egT4j" title="Conversion of notes payable-related parties and accrued interest, shares">149,979 shares of the Company’s common stock. The shares were valued at $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20260421__20260422__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--CommonStockMember_zTpYXJWtKm4a" title="Conversion of notes payable-related parties and accrued interest">427,440, or $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20260422__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--CommonStockMember_zVBfwf2Qm6a" title="Shares issued per share">2.85 per share. This resulted in a loss on debt extinguishment in the amount of $99,762. Included within the notes payable – related parties balance is a convertible note agreement entered on March 18, 2024 for $50,000. The convertible note was scheduled to mature on March 18, 2026 and carries an interest rate of 9.75% per annum. The principal and prior accrued interest of the note was convertible into shares of the Company’s common stock at $2.00 per share. On October 31, 2024, the Company amended the agreement with the holder of the note to change its maturity to the earlier of the date that the Company lists its securities on a national stock exchange or March 31, 2025 and eliminated the conversion feature of the note. Interest on the note accrues and is paid at maturity along with principal, as specifically described in the note. On April 25, 2025, the Company executed an extension of the maturity date until the earlier of the date the Company is able to achieve a listing on a national stock exchange or June 30, 2025. The note was extended again to December 31, 2025. On March 23, 2026, the Company executed an agreement whereby the Company is obligated to pay the holder $5,000 per month beginning on April 1, 2026 until the note is paid in full. Additionally, the Company agreed to issue 33,000 shares to the holder as consideration. The shares were issued on April 27, 2026 and were valued at $51,480. As of April 30, 2026, the principal balance of this note is $45,000. As of April 30, 2026, this holder is no longer considered a related party and as such this balance is now included under notes payable. On April 16, 2025, the Company issued an unsecured promissory note in the principal amount of $150,000 to Indicia Capital, LLC. The note bears interest at a rate of 9.75% per annum and matures on the earlier of (i) 180 days from the date of issuance or (ii) the date the Company receives at least $1,000,000 in new financing. In connection with the issuance of the note, the Chief Executive Officer and Director transferred <span id="xdx_900_ecustom--SharesTransferredForConsideration_c20250415__20250416__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember_znTqFSxX4kf2" title="Consideration transferred for convertible note">15,000 shares of the Company’s common stock to Indicia Capital as additional consideration to enter the loan. James Byrd, who serves as a co-manager and holds a 50% membership interest in Indicia Capital, was the original organizer of the Company by virtue of having founded the Company in October 2022. Accordingly, the transaction is considered a related party transaction. On March 23, 2026, the Company executed an agreement whereby the Company is obligated to pay the holder $5,000 per month beginning on April 1,2026 until the note is paid in full. As of April 30, 2026, the principal balance of this note is $145,000. As of April 30, 2026, this holder is no longer considered a related party and as such this balance is now included under notes payable. <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zzWDU0A5ZXWl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE - RELATED PARTIES (Details - Related parties)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of notes payables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Notes payable – related parties, current portion</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zagexn5CcSl2" style="width: 13%; text-align: right" title="Notes payable - related parties, current portion">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zSOoG5wHWLK3" style="width: 13%; text-align: right" title="Notes payable - related parties, current portion">841,613</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Notes payable – related parties, non-current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--LongTermNotesPayable_iI_d0_c20260430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_za4TcIq8TwM7" style="border-bottom: Black 1pt solid; text-align: right" title="Notes payable - related parties, non-current portion">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--LongTermNotesPayable_iI_c20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zwkOFgcUxxNl" style="border-bottom: Black 1pt solid; text-align: right" title="Notes payable - related parties, non-current portion">495,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total notes payable – related parties</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NotesPayable_iI_c20260430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zTAwoopwTjg4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total notes payable - related parties">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--NotesPayableRelatedPartiesNonCurrent_iI_c20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zxagQs1Zz8g2" style="border-bottom: Black 2.5pt double; text-align: right" title="Total notes payable - related parties">1,336,613</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1336613

969054

88712

7398459

1701646

0.23

643880

327629

149979

427440

2.85

99762

50000

2026-03-18

0.0975

2.00

5000

33000

51480

45000

150000

The note bears interest at a rate of 9.75% per annum and matures on the earlier of (i) 180 days from the date of issuance or (ii) the date the Company receives at least $1,000,000 in new financing.

15000

0.50

5000

145000

<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zzWDU0A5ZXWl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE - RELATED PARTIES (Details - Related parties)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of notes payables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Notes payable – related parties, current portion</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zagexn5CcSl2" style="width: 13%; text-align: right" title="Notes payable - related parties, current portion">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zSOoG5wHWLK3" style="width: 13%; text-align: right" title="Notes payable - related parties, current portion">841,613</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Notes payable – related parties, non-current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--LongTermNotesPayable_iI_d0_c20260430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_za4TcIq8TwM7" style="border-bottom: Black 1pt solid; text-align: right" title="Notes payable - related parties, non-current portion">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--LongTermNotesPayable_iI_c20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zwkOFgcUxxNl" style="border-bottom: Black 1pt solid; text-align: right" title="Notes payable - related parties, non-current portion">495,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total notes payable – related parties</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NotesPayable_iI_c20260430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zTAwoopwTjg4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total notes payable - related parties">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--NotesPayableRelatedPartiesNonCurrent_iI_c20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zxagQs1Zz8g2" style="border-bottom: Black 2.5pt double; text-align: right" title="Total notes payable - related parties">1,336,613</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

841613

495000

1336613

NOTE 5: NOTES PAYABLE The following table details the Company’s notes payable as of April 30, 2026 and October 31, 2025, respectively: <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfNotesPayableTableTextBlock_zOLbvW4XWZD6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE (Details - Notes payable)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">Schedule of notes payable</td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Original</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal Balance as of</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Date of Note</td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Principal</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">April 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">October 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref No.</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Issuance</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Balance</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">1*</td><td> </td> <td style="text-align: center">7/25/2018</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable1Member_zZDHvJt69YL4" style="text-align: right" title="Original Principal Balance">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable1Member_z9zFv32AipGi" style="text-align: right" title="Principal Balance">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable1Member_z5DvXnpwQZTe" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 18%; text-align: center">2</td><td style="width: 2%"> </td> <td style="width: 29%; text-align: center">3/12/2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable2Member_zFydm3WYc8Sj" style="width: 13%; text-align: right" title="Original Principal Balance">150,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable2Member_z13KBWiiaKh9" style="width: 13%; text-align: right" title="Principal Balance">150,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable2Member_zK1WbaPppPB1" style="width: 13%; text-align: right" title="Principal Balance">150,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">3*</td><td> </td> <td style="text-align: center">3/18/2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable3Member_zPVPaJmbO5ec" style="text-align: right" title="Original Principal Balance">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable3Member_zRRey4e7pr65" style="text-align: right" title="Principal Balance">45,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable3Member_z87eBzHxZdlb" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">4</td><td> </td> <td style="text-align: center">6/20/2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable4Member_ziIAzpZLuHhl" style="text-align: right" title="Original Principal Balance">400,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable4Member_zdBg5qGGzzM8" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable4Member_zviAcBDL7IN1" style="text-align: right" title="Principal Balance">400,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">5</td><td> </td> <td style="text-align: center">6/20/2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable5Member_zW6ZKv6R9fD7" style="text-align: right" title="Original Principal Balance">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable5Member_zfPfjye6dEyj" style="text-align: right" title="Principal Balance">45,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable5Member_zSZJ5O77jej2" style="text-align: right" title="Principal Balance">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">6</td><td> </td> <td style="text-align: center">7/31/2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable6Member_zaGNWdJpgFsj" style="text-align: right" title="Original Principal Balance">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable6Member_zKKm4kWmhNG8" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable6Member_zrEk5Xyw1589" style="text-align: right" title="Principal Balance">435,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">7</td><td> </td> <td style="text-align: center">7/31/2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable7Member_zEpsxxzgYvs2" style="text-align: right" title="Original Principal Balance">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable7Member_z3NBFZXDFgd4" style="text-align: right" title="Principal Balance">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable7Member_zp4vAXd8Zz54" style="text-align: right" title="Principal Balance">250,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">8</td><td> </td> <td style="text-align: center">1/9/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable8Member_zMcIwsxqIHed" style="text-align: right" title="Original Principal Balance">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable8Member_ztbv8JagxUDl" style="text-align: right" title="Principal Balance">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable8Member_zx83qG0yceNc" style="text-align: right" title="Principal Balance">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">9</td><td> </td> <td style="text-align: center">2/3/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable9Member_zAPzdnJqOgwh" style="text-align: right" title="Original Principal Balance">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable9Member_z6Nid6Ce7WJf" style="text-align: right" title="Principal Balance">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable9Member_zyBPb55yy8gl" style="text-align: right" title="Principal Balance">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">10*</td><td> </td> <td style="text-align: center">4/16/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable10Member_zpswMLD3Dfw6" style="text-align: right" title="Original Principal Balance">150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable10Member_z5qBt6XHSpAh" style="text-align: right" title="Principal Balance">145,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable10Member_zTgNCqQu9oT5" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">11*</td><td> </td> <td style="text-align: center">4/23/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable11Member_zGqMzaKhHDu1" style="text-align: right" title="Original Principal Balance">15,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable11Member_zdvLLZXdyv2k" style="text-align: right" title="Principal Balance">15,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable11Member_zAibdJCmkhP5" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">12</td><td> </td> <td style="text-align: center">5/19/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable12Member_z2OEQNVH2QR3" style="text-align: right" title="Original Principal Balance">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable12Member_zBALUHVP786" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable12Member_zHyWK5hyMSz3" style="text-align: right" title="Principal Balance">152,958</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">13</td><td> </td> <td style="text-align: center">6/8/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable13Member_z0qGsGZunaM5" style="text-align: right" title="Original Principal Balance">192,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable13Member_zQYb1TU0DBu3" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable13Member_zrBc26MCXggi" style="text-align: right" title="Principal Balance">92,308</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">14</td><td> </td> <td style="text-align: center">9/18/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable14Member_zSwi8NulN5md" style="text-align: right" title="Original Principal Balance">63,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable14Member_zTUdAOFWWUQj" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable14Member_z9P2pWXmv0F4" style="text-align: right" title="Principal Balance">50,400</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">15</td><td> </td> <td style="text-align: center">9/30/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable15Member_z3WvFaarXYrl" style="text-align: right" title="Original Principal Balance">60,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable15Member_zOQAoktsizP3" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable15Member_zcFPt0kkD27b" style="text-align: right" title="Principal Balance">46,667</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">16</td><td> </td> <td style="text-align: center">9/30/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable16Member_zyxUCHxh3qSd" style="text-align: right" title="Original Principal Balance">60,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable16Member_z4ydFIJquBr8" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable16Member_z4Ii05sriCU6" style="text-align: right" title="Principal Balance">46,368</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">17</td><td> </td> <td style="text-align: center">9/30/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable17Member_zPis1a5tl3k8" style="text-align: right" title="Original Principal Balance">80,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable17Member_zML8ZS2pmTWh" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable17Member_zLi4OgYcwrUk" style="text-align: right" title="Principal Balance">63,333</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">18**</td><td> </td> <td style="text-align: center">9/30/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable18Member_zY36P0lRpPyc" style="text-align: right" title="Original Principal Balance">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable18Member_z5ggx3aUFu94" style="text-align: right" title="Principal Balance">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable18Member_z7fnL6ohRYk3" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 1pt">19</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt">1/23/2026</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable19Member_zNEar8i1Nuaj" style="padding-bottom: 1pt; text-align: right" title="Original Principal Balance">100,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable19Member_zTmAQy2vzk1h" style="border-bottom: Black 1pt solid; text-align: right" title="Principal Balance">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable19Member_zCtMUuDWIw6f" style="border-bottom: Black 1pt solid; text-align: right" title="Principal Balance">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_c20260430_zSO2GumI8pgd" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal Balance">815,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20251031_zUq5jQg9yb4a" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal Balance">1,887,034</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 3%">*</td> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 97%">As of October 31, 2025, these noteholders were considered related parties. As of April 30, 2026, these noteholders are no longer considered related parties and their balances have been reclassified to notes payable. Their notes are described in Note 4 – Notes Payable, Related Parties.</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt"> </td> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt"> </td></tr> <tr style="vertical-align: top"> <td id="xdx_F0B_z5btd8hBJiDf" style="text-align: justify; padding-left: 10pt; text-indent: -10pt">**</td> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt">On April 23, 2026, this note balance was transferred from a related party to a non-related party for no consideration.</td></tr> </table> Note 2 On March 12, 2024, the Company executed a note payable agreement for $150,000. The note originally matured on March 12, 2025 and carries an interest rate of 12% per annum. On April 25, 2025, the Company executed an extension of the maturity date until the earlier of the date the Company is able to achieve a listing on a national stock exchange or June 30, 2025. The note was extended again to December 31, 2025 and again to September 30, 2026. Interest on the note accrues and is paid at maturity along with principal. Note 4 On June 20, 2024, the Company executed a convertible note payable agreement for $450,000 with a venture capital fund. The convertible note matures on June 20, 2026 and carries an interest rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240620__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreement4Member__us-gaap--AwardTypeAxis__custom--MaturesOnJune202026Member_zd0jfThcKfz1" title="Interest rate">9.75% per annum. The principal and prior accrued interest of the note were convertible into shares of the Company’s common stock at $2.00 per share. On October 7, 2024, $50,000 of the note payable was assigned to an unrelated holder. On October 17, 2024, the Company amended the agreement with the holder of the $400,000 note, which eliminated the conversion feature and advanced the date of the loan to November 5, 2025. Interest on the notes is paid quarterly or accrued and is to be repaid at maturity along with principal, as specifically described in the notes. The Company accounted for the amendment as an extinguishment of debt and recorded a loss of $8,100 on the condensed consolidated statements of operations for the year ended October 31, 2024. On July 2, 2025, the Company entered into separate Stockholder Pledge Agreement with the holder of $400,000 of the above notes with the Company’s former director and executive officer and Chief Operating Officer to secure the Company’s obligations. Pursuant to the Pledge Agreements, each Pledgor pledged 1,000,000 shares of the Company’s common stock as collateral. The Pledge Agreements require the pledged shares to maintain a collateral coverage ratio equal to 400% of the outstanding principal amount of the Notes, based on a $4.00 per share valuation. If the Secured Party delivers a collateral call notice due to a decline in the value of the pledged shares or a dilution event, the Pledgors or the Company are required to provide additional shares. Failure to do so may constitute an event of default under the Notes. On April 27, 2026, the holder agreed to settle the $400,000 principal balance and $21,156 in accrued interest related to this note along with $435,000 in principal and accrued interest of $23,007 related to Note 6 in exchange for 500,000 shares of the Company’s common stock which was given personally by a former officer of the Company. Since the settlement is considered a capital transaction, the Company has recorded $879,163 in common stock. Note 5 As mentioned above in Note 4, on October 7, 2024, $50,000 of the $450,000 principal was assigned to an unrelated holder. On October 31, 2024, the Company amended the agreement with the holder of the $50,000 note to change its maturity to the earlier of the Company listing on a national stock exchange or March 31, 2025 and eliminated the conversion feature of the note. On April 25, 2025, the Company executed a loan amendment for an extension of the maturity date until the earlier of the date the Company is able to achieve a listing on a national stock exchange or June 30, 2025. The note was extended again to December 31, 2025. On March 23, 2026, the Company executed an agreement whereby the Company is obligated to pay the holder $5,000 per month beginning on April 1, 2026 until the note is paid in full. Note 6 On July 31, 2024, the Company issued a convertible note payable agreement for $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreement6Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zOmIsr2JyoSd">250,000. The convertible note matured on <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20240730__20240731__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreement6Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zMZgIQy97Vuk">October 31, 2025 and carries an interest rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240731__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreement6Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z0XWD1BEiROe">13% per annum. <span id="xdx_905_eus-gaap--DebtInstrumentDescription_dd_c20240730__20240731__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreement6Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zHDWVbnvz6d3">The principal and prior accrued interest of the note was convertible into shares of the Company’s common stock at a price per share equal to a 30% discount per share of the final per-share price of a planned public offering. Subsequent to the issuance of the convertible note the Company amended the agreement with the holder which eliminated the conversion feature, changed the interest rate to 9.75% per annum, increased the principal of the note to $500,000, and extended the maturity date of the loan to November 5, 2025. Interest on the note either is paid quarterly or accrues and is paid at maturity along with principal, as specifically described in the note. Due to the elimination of the conversion feature the Company accounted for the amendment as a significant change resulting in an extinguishment of debt and recorded a loss of $<span id="xdx_90C_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20231101__20241031__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreement6Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zZD8ZhKnoHBa">15,750 on the condensed consolidated statements of operations for the year ended October 31, 2024. On July 2, 2025, the Company entered into separate Stockholder Pledge Agreement with the holder of the above note with the Company’s former director and executive officer and Chief Operating Officer to secure the Company’s obligations. Pursuant to the Pledge Agreements, each Pledgor pledged 1,000,000 shares of the Company’s common stock as collateral. The Pledge Agreements require the pledged shares to maintain a collateral coverage ratio equal to 400% of the outstanding principal amount of the Notes, based on a $4.00 per share valuation. If the Secured Party delivers a collateral call notice due to a decline in the value of the pledged shares or a dilution event, the Pledgors or the Company are required to provide additional shares. Failure to do so may constitute an event of default under the Notes. Note 7 On July 31, 2024, the Company executed a convertible note payable agreement for $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreement7Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zH0iicOeg8Ob">250,000. The convertible note matures on <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20240730__20240731__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreement7Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zV7EU78Gb7W7">May 1, 2025 and carries an interest rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240731__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreement7Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ziLZpWc60F1i">13% per annum. The principal and prior accrued interest of the note was convertible into shares of the Company’s common stock at $2.00 per share. The Company may not prepay the note within the first 180 days of the note date. Subsequent to the issuance of the convertible note the Company amended the agreement with the holder which eliminated the conversion feature, changed the interest rate to <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_dp_c20240730__20240731__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreement7Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zAOONxdHFmib">9.75% per annum, and extended the maturity date of the loan again to November 5, 2025. Interest on the note either accrues or is paid quarterly or at maturity along with principal. The Company accounted for the amendment as an extinguishment of debt and recorded a loss of $4,500 on the consolidated statements of operations for the year ended October 31, 2024. As of April, 30, 2026, this note is considered in default. Note 8 On January 9, 2025, the Company executed a note payable agreement for $50,000. The note matures on January 9, 2027 and carries an interest rate of 9.75% per annum. The Company may not prepay the note within the first 180 days of the note date. Interest on the note accrues and is paid at maturity along with principal. Note 9 On February 3, 2025, the Company executed a note payable agreement for $100,000. The note matures on February 9, 2027 and carries an interest rate of 9.75% per annum. Interest on the note accrues and is paid at maturity along with principal. Note 12 On May 19, 2025, the Company obtained a short-term loan, which totaled $ 250,000, from a single lender to fund operations. This loan included origination fees totaling $ 7,500 for net proceeds of $ 242,500. The loan is secured by expected (i) future cash receipts of the Company, and (ii) all other tangible and intangible personal property. Payments are expected on a weekly basis for 52 weeks. The Company is expected to repay an aggregate of $311,000 to the lender over the nominal term. The repayment amount decreases for earlier payoff dates. Note 13 On June 8, 2025, the Company entered into a Receivables Sale Agreement pursuant to which the Company sold receivables totaling $192,000 to a third party for $150,000 from which fees of $2,000 were deducted for net proceeds of $148,000. The purchasers right to receive remittances under this agreement is contingent upon the Company’s receipt of the receivables. The expected weekly repayment is $3,692 based on 3.27% of the Company estimated sales revenue. The estimated term is 1 year. The agreement is guaranteed by certain officers and directors of the Company. As of April 30, 2026, the remaining balance is $0 as the note has been fully repaid. Note 14 On September 18, 2025, the Company obtained a short-term loan, which totaled $ 63,000, from a single lender to fund operations. The loan is secured by expected (i) future cash receipts of the Company, and (ii) all other tangible and intangible personal property. Payments are expected on a weekly basis for 30 weeks. The Company is expected to repay an aggregate of $91,980 to the lender over the nominal term. The repayment amount decreases for earlier payoff dates. As of April 30, 2026, the remaining balance is $0 as the note has been fully repaid. Note 15 On September 30, 2025, the Company obtained a short-term loan, which totaled $ 60,000, from a single lender to fund operations. The loan is secured by expected (i) future cash receipts of the Company, and (ii) all other tangible and intangible personal property. Payments are expected on a weekly basis for 18 weeks. The Company is expected to repay an aggregate of $89,940 to the lender over the nominal term. The repayment amount decreases for earlier payoff dates. As of April 30, 2026, the remaining balance is $0 as the note has been fully repaid. Note 16 On September 30, 2025, the Company obtained a short-term loan, which totaled $ 60,000, from a single lender to fund operations. The loan is secured by expected (i) future cash receipts of the Company, and (ii) all other tangible and intangible personal property. Payments are expected on a weekly basis for 18 weeks. The Company is expected to repay an aggregate of $89,940 to the lender over the nominal term. The repayment amount decreases for earlier payoff dates. As of April 30, 2026, the remaining balance is $0 as the note has been fully repaid. Note 17 On September 30, 2025, the Company obtained a short-term loan, which totaled $ 80,000, from a single lender to fund operations. The loan is secured by expected (i) future cash receipts of the Company, and (ii) all other tangible and intangible personal property. Payments are expected on a weekly basis for 24 weeks. The Company is expected to repay an aggregate of $120,000 to the lender over the nominal term. The repayment amount decreases for earlier payoff dates. As of April 30, 2026, the remaining balance is $0 as the note has been fully repaid. The Company evaluated the Receivables Sale Agreement to determine if it meets the definition of a contract liability under ASC 606 or if it meets the definition of debt under ASC 470, Debt. The contract meets the definition of debt as there is no obligation to perform services and the instrument is to be repaid with cash. Note 19 On January 23, 2026, the Company issued a $100,000 note that is non-interest bearing and is due on demand. On April 30, 2026, the holder converted the $100,000 note into 250,000 shares of Series D Convertible Preferred Stock. <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zQROMZMCzQtj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of notes payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20260430_zi0R9xu2Ib4g" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20251031_z11MsrQSCmi1" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--NotesPayableCurrent_iI_zAqFfUHdGV42" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Notes payable, current</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">730,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,737,034</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermNotesPayable_iI_d0_zIJgBgzEO4rc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Notes payable, less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">85,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">150,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NotesPayable_iI_z8Lsx5Z50er9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total notes payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">815,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,887,034</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The aggregate maturity on the notes payable as of April 30, 2026, are as follows: <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zN08SrLlbmE1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE (Details - Aggregate maturity on notes payable)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of aggregate maturity on the notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Due in less than one year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableMember_zJk5tfOx3gmh" style="width: 13%; text-align: right" title="Due in less than one year">730,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Due after one year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableMember_zCDXblexiQA1" style="border-bottom: Black 1pt solid; text-align: right" title="Due after one year">85,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableMember_zKWPfU15p9i9" style="text-align: right" title="Long-term debt">815,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--NotesPayableCurrent_iNI_di_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableMember_zOpy3aVgydNd" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(730,500</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Notes payable, non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--LongTermNotesPayable_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableMember_z68q5TlLtiza" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, non-current portion">85,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfNotesPayableTableTextBlock_zOLbvW4XWZD6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE (Details - Notes payable)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">Schedule of notes payable</td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Original</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal Balance as of</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Date of Note</td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Principal</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">April 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">October 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref No.</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Issuance</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Balance</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">1*</td><td> </td> <td style="text-align: center">7/25/2018</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable1Member_zZDHvJt69YL4" style="text-align: right" title="Original Principal Balance">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable1Member_z9zFv32AipGi" style="text-align: right" title="Principal Balance">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable1Member_z5DvXnpwQZTe" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 18%; text-align: center">2</td><td style="width: 2%"> </td> <td style="width: 29%; text-align: center">3/12/2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable2Member_zFydm3WYc8Sj" style="width: 13%; text-align: right" title="Original Principal Balance">150,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable2Member_z13KBWiiaKh9" style="width: 13%; text-align: right" title="Principal Balance">150,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable2Member_zK1WbaPppPB1" style="width: 13%; text-align: right" title="Principal Balance">150,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">3*</td><td> </td> <td style="text-align: center">3/18/2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable3Member_zPVPaJmbO5ec" style="text-align: right" title="Original Principal Balance">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable3Member_zRRey4e7pr65" style="text-align: right" title="Principal Balance">45,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable3Member_z87eBzHxZdlb" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">4</td><td> </td> <td style="text-align: center">6/20/2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable4Member_ziIAzpZLuHhl" style="text-align: right" title="Original Principal Balance">400,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable4Member_zdBg5qGGzzM8" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable4Member_zviAcBDL7IN1" style="text-align: right" title="Principal Balance">400,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">5</td><td> </td> <td style="text-align: center">6/20/2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable5Member_zW6ZKv6R9fD7" style="text-align: right" title="Original Principal Balance">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable5Member_zfPfjye6dEyj" style="text-align: right" title="Principal Balance">45,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable5Member_zSZJ5O77jej2" style="text-align: right" title="Principal Balance">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">6</td><td> </td> <td style="text-align: center">7/31/2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable6Member_zaGNWdJpgFsj" style="text-align: right" title="Original Principal Balance">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable6Member_zKKm4kWmhNG8" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable6Member_zrEk5Xyw1589" style="text-align: right" title="Principal Balance">435,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">7</td><td> </td> <td style="text-align: center">7/31/2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable7Member_zEpsxxzgYvs2" style="text-align: right" title="Original Principal Balance">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable7Member_z3NBFZXDFgd4" style="text-align: right" title="Principal Balance">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable7Member_zp4vAXd8Zz54" style="text-align: right" title="Principal Balance">250,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">8</td><td> </td> <td style="text-align: center">1/9/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable8Member_zMcIwsxqIHed" style="text-align: right" title="Original Principal Balance">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable8Member_ztbv8JagxUDl" style="text-align: right" title="Principal Balance">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable8Member_zx83qG0yceNc" style="text-align: right" title="Principal Balance">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">9</td><td> </td> <td style="text-align: center">2/3/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable9Member_zAPzdnJqOgwh" style="text-align: right" title="Original Principal Balance">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable9Member_z6Nid6Ce7WJf" style="text-align: right" title="Principal Balance">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable9Member_zyBPb55yy8gl" style="text-align: right" title="Principal Balance">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">10*</td><td> </td> <td style="text-align: center">4/16/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable10Member_zpswMLD3Dfw6" style="text-align: right" title="Original Principal Balance">150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable10Member_z5qBt6XHSpAh" style="text-align: right" title="Principal Balance">145,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable10Member_zTgNCqQu9oT5" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">11*</td><td> </td> <td style="text-align: center">4/23/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable11Member_zGqMzaKhHDu1" style="text-align: right" title="Original Principal Balance">15,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable11Member_zdvLLZXdyv2k" style="text-align: right" title="Principal Balance">15,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable11Member_zAibdJCmkhP5" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">12</td><td> </td> <td style="text-align: center">5/19/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable12Member_z2OEQNVH2QR3" style="text-align: right" title="Original Principal Balance">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable12Member_zBALUHVP786" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable12Member_zHyWK5hyMSz3" style="text-align: right" title="Principal Balance">152,958</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">13</td><td> </td> <td style="text-align: center">6/8/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable13Member_z0qGsGZunaM5" style="text-align: right" title="Original Principal Balance">192,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable13Member_zQYb1TU0DBu3" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable13Member_zrBc26MCXggi" style="text-align: right" title="Principal Balance">92,308</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">14</td><td> </td> <td style="text-align: center">9/18/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable14Member_zSwi8NulN5md" style="text-align: right" title="Original Principal Balance">63,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable14Member_zTUdAOFWWUQj" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable14Member_z9P2pWXmv0F4" style="text-align: right" title="Principal Balance">50,400</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">15</td><td> </td> <td style="text-align: center">9/30/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable15Member_z3WvFaarXYrl" style="text-align: right" title="Original Principal Balance">60,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable15Member_zOQAoktsizP3" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable15Member_zcFPt0kkD27b" style="text-align: right" title="Principal Balance">46,667</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">16</td><td> </td> <td style="text-align: center">9/30/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable16Member_zyxUCHxh3qSd" style="text-align: right" title="Original Principal Balance">60,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable16Member_z4ydFIJquBr8" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable16Member_z4Ii05sriCU6" style="text-align: right" title="Principal Balance">46,368</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">17</td><td> </td> <td style="text-align: center">9/30/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable17Member_zPis1a5tl3k8" style="text-align: right" title="Original Principal Balance">80,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable17Member_zML8ZS2pmTWh" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--NotesPayableCurrent_iI_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable17Member_zLi4OgYcwrUk" style="text-align: right" title="Principal Balance">63,333</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">18**</td><td> </td> <td style="text-align: center">9/30/2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable18Member_zY36P0lRpPyc" style="text-align: right" title="Original Principal Balance">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable18Member_z5ggx3aUFu94" style="text-align: right" title="Principal Balance">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable18Member_z7fnL6ohRYk3" style="text-align: right" title="Principal Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 1pt">19</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt">1/23/2026</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable19Member_zNEar8i1Nuaj" style="padding-bottom: 1pt; text-align: right" title="Original Principal Balance">100,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayableCurrent_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable19Member_zTmAQy2vzk1h" style="border-bottom: Black 1pt solid; text-align: right" title="Principal Balance">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--NotesPayableCurrent_iI_d0_c20251031__us-gaap--LongtermDebtTypeAxis__custom--NotesPayable19Member_zCtMUuDWIw6f" style="border-bottom: Black 1pt solid; text-align: right" title="Principal Balance">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_c20260430_zSO2GumI8pgd" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal Balance">815,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20251031_zUq5jQg9yb4a" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal Balance">1,887,034</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2018-07-25

10000

2024-03-12

150000

2024-03-18

50000

45000

2024-06-20

400000

2024-06-20

50000

45000

50000

2024-07-31

500000

435000

2024-07-31

250000

2025-01-09

50000

2025-02-03

100000

2025-04-16

150000

145000

2025-04-23

15500

2025-05-19

250000

152958

2025-06-08

192000

92308

2025-09-18

63000

50400

2025-09-30

60000

46667

2025-09-30

60000

46368

2025-09-30

80000

63333

2025-09-30

5000

2026-01-23

100000

815500

1887034

150000

2025-03-12

0.12

450000

2026-06-20

0.0975

2.00

On October 7, 2024, $50,000 of the note payable was assigned to an unrelated holder. On October 17, 2024, the Company amended the agreement with the holder of the $400,000 note, which eliminated the conversion feature and advanced the date of the loan to November 5, 2025. Interest on the notes is paid quarterly or accrued and is to be repaid at maturity along with principal, as specifically described in the notes.

8100

On July 2, 2025, the Company entered into separate Stockholder Pledge Agreement with the holder of $400,000 of the above notes with the Company’s former director and executive officer and Chief Operating Officer to secure the Company’s obligations. Pursuant to the Pledge Agreements, each Pledgor pledged 1,000,000 shares of the Company’s common stock as collateral. The Pledge Agreements require the pledged shares to maintain a collateral coverage ratio equal to 400% of the outstanding principal amount of the Notes, based on a $4.00 per share valuation. If the Secured Party delivers a collateral call notice due to a decline in the value of the pledged shares or a dilution event, the Pledgors or the Company are required to provide additional shares. Failure to do so may constitute an event of default under the Notes.

50000

5000

250000

2025-10-31

0.13

The principal and prior accrued interest of the note was convertible into shares of the Company’s common stock at a price per share equal to a 30% discount per share of the final per-share price of a planned public offering. Subsequent to the issuance of the convertible note the Company amended the agreement with the holder which eliminated the conversion feature, changed the interest rate to 9.75% per annum, increased the principal of the note to $500,000, and extended the maturity date of the loan to November 5, 2025. Interest on the note either is paid quarterly or accrues and is paid at maturity along with principal, as specifically described in the note.

15750

1000000 4

4.00

250000

2025-05-01

0.13

2.00

0.0975

4500

50000

2027-01-09

0.0975

100000

2027-02-09

0.0975

250000

7500

242500

52 weeks

311000

192000

150000

2000

148000

3692

0.0327

63000

30 weeks

91980

60000

18 weeks

89940

60000

18 weeks

89940

80000

24 weeks

120000

100000

250000

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zQROMZMCzQtj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of notes payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20260430_zi0R9xu2Ib4g" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20251031_z11MsrQSCmi1" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--NotesPayableCurrent_iI_zAqFfUHdGV42" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Notes payable, current</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">730,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,737,034</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermNotesPayable_iI_d0_zIJgBgzEO4rc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Notes payable, less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">85,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">150,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NotesPayable_iI_z8Lsx5Z50er9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total notes payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">815,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,887,034</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

730500

1737034

85000

150000

815500

1887034

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zN08SrLlbmE1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE (Details - Aggregate maturity on notes payable)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of aggregate maturity on the notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Due in less than one year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayableCurrent_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableMember_zJk5tfOx3gmh" style="width: 13%; text-align: right" title="Due in less than one year">730,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Due after one year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableMember_zCDXblexiQA1" style="border-bottom: Black 1pt solid; text-align: right" title="Due after one year">85,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--NotesPayable_iI_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableMember_zKWPfU15p9i9" style="text-align: right" title="Long-term debt">815,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--NotesPayableCurrent_iNI_di_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableMember_zOpy3aVgydNd" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(730,500</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Notes payable, non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--LongTermNotesPayable_iI_d0_c20260430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableMember_z68q5TlLtiza" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, non-current portion">85,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

730500

85000

815500

730500

85000

NOTE 6: CONVERTIBLE NOTES PAYABLE On August 26, 2025, the Company executed a note payable agreement for $<span id="xdx_90E_eus-gaap--ConvertibleNotesPayable_iI_c20250826__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zmA2hj8JJcY6">275,000 from which $<span id="xdx_903_eus-gaap--PaymentsForFees_c20250825__20250826__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z9YqWmKiMq4a">75,000 in fees were deducted for net proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_c20250825__20250826__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zqsIoSsEMcFh">200,000. The note matures on <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20250825__20250826__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zK0bL7NAlYU5">August 26, 2026 and carries an interest rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20250826__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zTXraQkPVxMk">10% per annum. Interest on the note accrues and is paid at maturity along with principal, as specifically described in the note. In addition, the Company issued <span id="xdx_909_ecustom--SharesTransferredForConsideration_c20250825__20250826__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z6H4LS7Ck64e">25,000 unregistered shares of its common stock (the “Commitment Shares”), to the Buyer as additional consideration. <span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20250825__20250826__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zTnDAee5vxEk">The Note is convertible, upon certain events of default or missed payments, into shares of the Company’s common stock at a price equal to 90% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice). On February 24, 2026, the Company repaid $<span id="xdx_902_eus-gaap--RepaymentsOfConvertibleDebt_c20260223__20260224__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zjPENuhcD9yl">137,188 in principal and $<span id="xdx_90C_eus-gaap--InterestPaid_c20260223__20260224__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zK3uBH09KvLh">13,562 in accrued interest. On March 2, 2026, the holder converted the remaining principal balance of $<span id="xdx_90F_eus-gaap--DebtConversionOriginalDebtAmount1_c20260301__20260302__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z27JRCrALDU3">137,812 and $<span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20260301__20260302__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--AccruedInterestMember_zsJKNFm0XbVe">227 in accrued interest into <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20260301__20260302__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zmk67TPCyRj7">127,712 shares of common stock. The shares were valued at $<span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20260301__20260302__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ztNvhYozrMm2">279,689, or $2.19 per share. This resulted in a loss on debt extinguishment in the amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260302__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zvowbRMGMMM4">141,650. On December 19, 2025, the Company executed a note payable agreement for $<span id="xdx_90A_eus-gaap--ConvertibleNotesPayable_iI_c20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementOneMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zHXj9VpGZmH">65,205 from which $<span id="xdx_90F_eus-gaap--PaymentsForFees_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementOneMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zZ34i00J7Urd">8,505 in fees were deducted for net proceeds of $<span id="xdx_906_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementOneMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zGma9z9Nkjqd">56,700. The note matures on <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementOneMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z6nAF1ad7Blf">October 15, 2026 and carries an interest rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementOneMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zpUfL8IV3awc">12% per annum. Interest on the note accrues and is paid at maturity along with principal. <span id="xdx_907_eus-gaap--DebtInstrumentDescription_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementOneMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zbwUaQYf5Q2f">The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 65% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice). On December 19, 2025, the Company executed a note payable agreement for $<span id="xdx_90A_eus-gaap--ConvertibleNotesPayable_iI_c20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementTwoMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zmf9vr6TICue">127,010 from which $<span id="xdx_90E_eus-gaap--PaymentsForFees_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementTwoMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z5DoH7Ysr7qk">22,010 in fees were deducted for net proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementTwoMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zQKKMU8AYlgh">105,000. The note matures on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementTwoMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zD2sFFpWIib">December 15, 2026 and carries an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementTwoMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zxlQCUek0Jd2">12% per annum. Interest on the note accrues and is paid at maturity along with principal. <span id="xdx_902_eus-gaap--DebtInstrumentDescription_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementTwoMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zEZjc1AXh1le">The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 65% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice). On December 19, 2025, the Company executed a note payable agreement for $<span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_c20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementThreeMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zq5cVQbSZbG3">65,205 from which $<span id="xdx_909_eus-gaap--PaymentsForFees_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementThreeMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_znFTzLYSfo2f">16,905 in fees were deducted for net proceeds of $<span id="xdx_906_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementThreeMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zSsNjYvoLZ6h">48,300. The note matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementThreeMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zpT0dizXVcj">October 15, 2026 and carries an interest rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementThreeMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ztJbsvCEGhw1">12% per annum. Interest on the note accrues and is paid at maturity along with principal. <span id="xdx_902_eus-gaap--DebtInstrumentDescription_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementThreeMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zrJWqK5VS3H1">The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 65% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice). On January 12, 2026, the Company executed a note payable agreement for $<span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_c20260112__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFourMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z1ZAuSC5xgVf">165,000 from which $<span id="xdx_90A_eus-gaap--PaymentsForFees_c20260111__20260112__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFourMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zvj2MnqbnZvg">30,500 in fees were deducted for net proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_c20260111__20260112__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFourMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zffgG9oxTd25">134,500. The note matures on <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20260111__20260112__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFourMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zzV0ud8SZOs3">January 12, 2027 and carries an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260112__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFourMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zzK6r6quJmb9">10% per annum. Interest on the note accrues and is paid at maturity along with principal. In addition, the Company issued <span id="xdx_90F_ecustom--SharesTransferredForConsideration_c20251218__20251219__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementThreeMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zQHVeVtaVSy1">75,000 unregistered shares of its common stock (the “Commitment Shares”), to the Buyer as additional consideration. <span id="xdx_902_eus-gaap--DebtInstrumentDescription_c20260111__20260112__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFourMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zfytFOB10Z4j">The Note is convertible, upon certain events of default or missed payments, into shares of the Company’s common stock at a price equal to 90% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice). On March 5, 2026, the Company repaid $<span id="xdx_906_eus-gaap--DebtInstrumentIssuedPrincipal_c20260304__20260305__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFourMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zDYdvIgdhici">165,000 in principal and $<span id="xdx_901_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20260304__20260305__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFourMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zkjMxQlwSAO7">16,500 in accrued interest. On January 14, 2026, the Company executed a note payable agreement for $<span id="xdx_903_eus-gaap--ConvertibleNotesPayable_iI_c20260114__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFiveMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z3QKbcBhvLQ1">165,000 from which $<span id="xdx_90F_eus-gaap--PaymentsForFees_c20260113__20260114__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFiveMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zdp0MjYMrtJ7">32,000 in fees were deducted for net proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_c20260113__20260114__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFiveMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z008W70iapPj">133,000. The note matures on <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20260113__20260114__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFiveMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zz2hWWDK4Pwc">January 14, 2027 and carries an interest rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260114__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFiveMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zwYyJamjFkJ9">10% per annum. Interest on the note accrues and is paid at maturity along with principal. In addition, the Company issued <span id="xdx_904_ecustom--SharesTransferredForConsideration_c20260113__20260114__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFiveMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zHndxJ4GHzp5">75,000 unregistered shares of its common stock (the “Commitment Shares”), to the Buyer as additional consideration. In connection with the note agreement, the Company issued 330,000 warrants with an exercise price of $0.50 per share, subject to change, and a five year term and can be net settled in cash in certain situations. <span id="xdx_901_eus-gaap--DebtInstrumentDescription_c20260113__20260114__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementFiveMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zcjV9T8Vfnif">The Note is convertible into shares of the Company’s common stock at a price equal to the lesser of (i) $0.50. or 80% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice). On February 6, 2026, the Company executed a note payable agreement for $<span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_c20260206__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSixMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zCxfXeIJzXFa">200,000 from which $<span id="xdx_906_eus-gaap--PaymentsForFees_c20260203__20260206__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSixMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zkH2nbPdKU79">25,000 in fees were deducted for net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_c20260203__20260206__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSixMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zmAtYGbo5Xo7">175,000. The note matures on <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20260203__20260206__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSixMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zDoduS7zpJ73">February 9, 2027 and carries an interest rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260206__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSixMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zQ9uIZ2e4CMd">6% per annum. Interest on the note accrues and is paid at maturity along with principal. <span id="xdx_90E_eus-gaap--DebtInstrumentDescription_c20260203__20260206__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSixMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zYgXiL4x0p3a">The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 60% of the lowest closing price during the 20 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice). On February 13, 2026, the Company executed a note payable agreement for $<span id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_c20260213__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSevenMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zijJt3zmdUQg">150,000 from which $<span id="xdx_909_eus-gaap--PaymentsForFees_c20260212__20260213__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSevenMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zVinK0ibpoqk">15,000 in fees were deducted for net proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_c20260212__20260213__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSevenMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zkWF7RKcjkme">135,000. The note matures on <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20260212__20260213__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSevenMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zdHuMLIa96n1">February 13, 2027 and carries an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260213__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSevenMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z9OXYq5peKr6">12% per annum. Interest on the note accrues and is paid at maturity along with principal. <span id="xdx_90A_eus-gaap--DebtInstrumentDescription_c20260212__20260213__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementSevenMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zl2MoaiGpsdf">The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 70% of the lowest closing price during the 15 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice). On February 17, 2026, the Company executed a note payable agreement for $<span id="xdx_903_eus-gaap--ConvertibleNotesPayable_iI_c20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementEightMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zd3RZKjoXek1">172,222 from which $<span id="xdx_905_eus-gaap--PaymentsForFees_c20260216__20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementEightMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zl8ytgzp5JOh">22,222 in fees were deducted for net proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_c20260216__20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementEightMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zwfNPckAf0Tk">150,000. The note matures on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20260216__20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementEightMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zGpibjY92zJ9">February 17, 2027 and carries an interest rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementEightMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z95F32i4s846">6% per annum. Interest on the note accrues and is paid at maturity along with principal. <span id="xdx_909_eus-gaap--DebtInstrumentDescription_c20260216__20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementEightMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zVKfAnOCdlWi">The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 60% of the lowest closing price during the 20 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice). On February 17, 2026, the Company executed a note payable agreement for $<span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_c20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementNineMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zg9OZa8kouJ6">238,050 from which $<span id="xdx_909_eus-gaap--PaymentsForFees_c20260216__20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementNineMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zCT3jytJyul9">38,050 in fees were deducted for net proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_c20260216__20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementNineMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zDT2G8pYGPYg">200,000. The note matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20260216__20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementNineMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z8EMvRjfgSj4">December 15, 2026 and carries an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementNineMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zdFSZ7SHIzmh">12% per annum. Interest on the note accrues and is paid at maturity along with principal. <span id="xdx_90A_eus-gaap--DebtInstrumentDescription_c20260216__20260217__us-gaap--DebtInstrumentAxis__custom--NotePayableAgreementNineMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z2eRPZCBDci4">The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 65% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice). The aggregate maturity on the convertible notes payable as of April 30, 2026, are as follows: <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ConvertibleDebtTableTextBlock_zfSDFVWhFqw" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONVERTIBLE NOTES PAYABLE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of maturity on the convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Due in less than one year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_c20260430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zSIE8qfZCYHa" style="width: 13%; text-align: right" title="Due in less than one year">488,237</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Due after one year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_d0_c20260430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zr9DZDB3hdlk" style="border-bottom: Black 1pt solid; text-align: right" title="Due after one year">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_c20260430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zzBIb0X7dvWk" style="text-align: right" title="Long-term debt">488,237</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--LongTermDebtCurrent_iNI_di_c20260430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_znacbCUp3DEg" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(488,237</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Convertible notes payable, non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleLongTermNotesPayable_iI_d0_c20260430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zFSpPjucB6V1" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible notes payable, non-current portion">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

275000

75000

200000

2026-08-26

0.10

25000

The Note is convertible, upon certain events of default or missed payments, into shares of the Company’s common stock at a price equal to 90% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice).

137188

13562

137812

227

127712

279689

141650

65205

8505

56700

2026-10-15

0.12

The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 65% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice).

127010

22010

105000

2026-12-15

0.12

65205

16905

48300

2026-10-15

0.12

165000

30500

134500

2027-01-12

0.10

75000

165000

16500

165000

32000

133000

2027-01-14

0.10

75000

330000

0.50

The Note is convertible into shares of the Company’s common stock at a price equal to the lesser of (i) $0.50. or 80% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice).

200000

25000

175000

2027-02-09

0.06

The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 60% of the lowest closing price during the 20 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice).

150000

15000

135000

2027-02-13

0.12

The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 70% of the lowest closing price during the 15 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice).

172222

22222

150000

2027-02-17

0.06

The Note is convertible, following the last to occur, (i) 180 days following the inception date or (ii) an event of default, into shares of the Company’s common stock at a price equal to 60% of the lowest closing price during the 20 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days’ notice).

238050

38050

200000

2026-12-15

0.12

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ConvertibleDebtTableTextBlock_zfSDFVWhFqw" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONVERTIBLE NOTES PAYABLE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of maturity on the convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Due in less than one year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_c20260430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zSIE8qfZCYHa" style="width: 13%; text-align: right" title="Due in less than one year">488,237</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Due after one year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_d0_c20260430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zr9DZDB3hdlk" style="border-bottom: Black 1pt solid; text-align: right" title="Due after one year">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_c20260430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zzBIb0X7dvWk" style="text-align: right" title="Long-term debt">488,237</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--LongTermDebtCurrent_iNI_di_c20260430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_znacbCUp3DEg" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(488,237</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Convertible notes payable, non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleLongTermNotesPayable_iI_d0_c20260430__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zFSpPjucB6V1" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible notes payable, non-current portion">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

488237

NOTE 7 – DERIVATIVE FINANCIAL INSTRUMENTS Embedded derivatives The Company’s convertible promissory notes gave rise to derivative financial instruments. The notes embodied certain terms and conditions that were not clearly and closely related to the host debt agreement in terms of economic risks and characteristics. These terms and features consist of the embedded conversion option. The following tables summarize the components of the Company’s derivative liabilities and linked common shares as of April 30, 2026 and October 31, 2025 and the amounts that were reflected in operations related to derivatives for the period ended: <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zp8GQ1oBUyUa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details - Derivative liabilities)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Schedule of derivative liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">The financings giving rise to derivative financial instruments</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Indexed Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Values</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Embedded derivative liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--IndexedSharesEmbeddedDerivatives_iI_c20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zHWkY5YVK106" style="width: 13%; text-align: right" title="Indexed Shares">5,188,200</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_z3dYNDHcF3Ea" style="width: 13%; text-align: right" title="Fair Values">621,423</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_ecustom--IndexedSharesEmbeddedDerivatives_iI_c20260430_zmFpxu6eol05" style="border-bottom: Black 2.5pt double; text-align: right" title="Indexed Shares">5,188,200</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20260430_zrFvPyMOvqPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Values">621,423</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">The financings giving rise to derivative financial instruments</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Indexed Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Values</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Embedded derivative liabilities</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98F_ecustom--IndexedSharesEmbeddedDerivatives_iI_c20251031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_znEYxBwNOJgj" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Indexed Shares">393,717</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20251031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zBDqccXX66yi" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Fair Values">39,543</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_ecustom--IndexedSharesEmbeddedDerivatives_iI_c20251031_z2khQCM16vV4" style="border-bottom: Black 2.5pt double; text-align: right" title="Indexed Shares">393,717</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20251031_z4ECFphkFJv4" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Values">39,543</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The following table summarizes the effects on the Company’s loss associated with changes in the fair values of the derivative financial instruments by type of financing for the three and six months ended April 30, 2026 and 2025: <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_zcNFgPYneHQa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details - Changes in the fair values of the derivative)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of changes in the fair values of the derivative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three months Ended</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Embedded derivative liability</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260201__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zYUawYLFcD0d" style="width: 13%; text-align: right" title="Derivative gain or loss on derivative, net">(8,644</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250201__20250430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zidnwTAX3wUd" style="width: 13%; text-align: right" title="Derivative gain or loss on derivative, net"> –</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Warrant derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260201__20260430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantDerivativeLiabilityMember_zaIYaUK4Q2me" style="border-bottom: Black 1pt solid; text-align: right" title="Derivative gain or loss on derivative, net">(121,506</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250201__20250430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantDerivativeLiabilityMember_zufY9xeiXCn6" style="border-bottom: Black 1pt solid; text-align: right" title="Derivative gain or loss on derivative, net">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total gain (loss)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260201__20260430_zImZEJAl25da" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative gain or loss on derivative, net">(130,150</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250201__20250430_zutzXv04t6q7" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative gain or loss on derivative, net">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Six months Ended</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Embedded derivative liability</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeGainLossOnDerivativeNet_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zlAbvUor8f4d" style="width: 13%; text-align: right" title="Derivative gain or loss on derivative, net">(478</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20241101__20250430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_z7S446vjAtPj" style="width: 13%; text-align: right" title="Derivative gain or loss on derivative, net"> –</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Warrant derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantDerivativeLiabilityMember_z4GE9lYXUDAi" style="border-bottom: Black 1pt solid; text-align: right" title="Derivative gain or loss on derivative, net">(318,464</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20241101__20250430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantDerivativeLiabilityMember_zDSOLQexfKI8" style="border-bottom: Black 1pt solid; text-align: right" title="Derivative gain or loss on derivative, net">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total gain (loss)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeGainLossOnDerivativeNet_c20251101__20260430_zeKDlMy1cxsa" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative gain or loss on derivative, net">(318,942</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20241101__20250430_zHCiWqsq8Jhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative gain or loss on derivative, net">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Current accounting principles that are provided in ASC 815 - Derivatives and Hedging require derivative financial instruments to be classified in liabilities and carried at fair value with changes recorded in operations. The Company has selected the Lattice Model valuation technique to fair value the embedded derivatives because it believes that this technique is reflective of all significant assumption types, and ranges of assumption inputs, that market participants would likely consider in transactions involving embedded derivatives. Such assumptions include, among other inputs, interest risk assumptions, credit risk assumptions and redemption behaviors in addition to traditional inputs for option models such as market trading volatility and risk-free rates. The Lattice Model technique is a level three valuation technique because it requires the development of significant internal assumptions in addition to observable market indicators. For instruments in which the time to expiration has passed, the Company has utilized the intrinsic value as the fair value. The intrinsic value is the difference between the quoted market price on the valuation date and the applicable conversion price. Significant range of inputs and results arising from the Lattice Model process are as follows for the embedded derivatives that have been bifurcated from the convertible notes and classified in liabilities: <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zfaVtfROZDXb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details - range of inputs by valuation technique)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Schedule of range of inputs from Lattice Model</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Inception Dates Note </td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Period Ended April 30, 2026 </td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 62%; text-align: justify">Underlying price on valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_906_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260826__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zYuAZWGMYtqi" title="Underlying price on valuation date">0.33 - <span id="xdx_902_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260826__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zTrjG1xbotyc" title="Underlying price on valuation date">1.03</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">$<span id="xdx_90D_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zigDEwX8b42k" title="Underlying price on valuation date">0.33 - <span id="xdx_90E_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_z2wLPdeOWX33" title="Underlying price on valuation date">0.42</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Effective contractual conversion rates</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_903_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260826__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputConversionPriceMember_zDywsvl4lWi3" title="Underlying price on valuation date">0.20 - <span id="xdx_903_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260826__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputConversionPriceMember_z04OUWkvsah4" title="Underlying price on valuation date">0.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">$<span id="xdx_906_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputConversionPriceMember_zNP4YRSz5PX" title="Underlying price on valuation date">0.20 - <span id="xdx_90D_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputConversionPriceMember_z83NZ1GFg3E8" title="Underlying price on valuation date">0.36</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Contractual term to maturity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uYear_c20260826__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zO3JOMd24n03" title="Underlying price on valuation date">0.49 - <span id="xdx_908_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uYear_c20260826__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zDznnGd2OPhh" title="Underlying price on valuation date">1.00 years</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uYear_c20260430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zzC9XNRRGKXf" title="Underlying price on valuation date">0.13 - <span id="xdx_90F_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uYear_c20260430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z9lh2rZadsF6" title="Underlying price on valuation date">0.70 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Market volatility:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260826__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zxjvwN8y5mOk" title="Underlying price on valuation date">20.47 - <span id="xdx_906_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260826__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z7KweNylikzj" title="Underlying price on valuation date">26.90%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zRnIkEJu5sF2" title="Underlying price on valuation date">21.73 - <span id="xdx_90B_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zVmm0vLUG4c7" title="Underlying price on valuation date">24.04%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Risk-adjusted interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260826__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zQ3l5OD3LQv6" title="Underlying price on valuation date">3.43 - <span id="xdx_901_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260826__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z7EePifxt2Ch" title="Underlying price on valuation date">4.06%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zIpU6CPzB5b2" title="Underlying price on valuation date">3.71 - <span id="xdx_902_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z1xaHP05ugma" title="Embedded derivative liability, measurement input">3.76%</td><td style="text-align: left"> </td></tr> </table> The detachable warrants issued with the convertible notes require derivative liability classification due to agreements containing a fundamental transaction clause which could require net cash settlement in certain situations. The warrant fair value was calculated using the Black-Scholes option pricing model using the following inputs: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Inception</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dates Note</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify">Underlying price on valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pip0_uUSDPShares_c20260826__us-gaap--ValuationTechniqueAxis__custom--IncomeApproachValuationTechniqueBlackScholesMember__us-gaap--MeasurementInputTypeAxis__custom--UnderlyingPriceOnValuationDateMember_zBYOwQe8t333">0.60</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Effective contractual conversion rates</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pip0_uUSDPShares_c20260826__us-gaap--ValuationTechniqueAxis__custom--IncomeApproachValuationTechniqueBlackScholesMember__us-gaap--MeasurementInputTypeAxis__custom--EffectiveContractualConversionRatesMember_zvLn18MxyTfe">0.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Contractual term to maturity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pip0_uYear_c20260826__us-gaap--ValuationTechniqueAxis__custom--IncomeApproachValuationTechniqueBlackScholesMember__us-gaap--MeasurementInputTypeAxis__custom--ContractualTermToMaturityMember_zleEIB9fbjM8">5.00 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Market volatility:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pip0_uPure_c20260826__us-gaap--ValuationTechniqueAxis__custom--IncomeApproachValuationTechniqueBlackScholesMember__us-gaap--MeasurementInputTypeAxis__custom--MarketVolatilityMember_zmgLEtCQno6">23.36%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Risk-adjusted interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pip0_uPure_c20260826__us-gaap--ValuationTechniqueAxis__custom--IncomeApproachValuationTechniqueBlackScholesMember__us-gaap--MeasurementInputTypeAxis__custom--RiskAdjustedInterestRateMember_zWuABeeT5D4i" title="Warrants and rights outstanding, measurement input">3.72%</td><td style="text-align: left"> </td></tr> </table> The following table reflects the issuances of derivatives and changes in fair value inputs and assumptions related to the embedded derivatives for the six months ended April 30, 2026. <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zyaW49Ksxsya" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details - Changes in fair value inputs)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of changes in fair value inputs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify">Balances at beginning of period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zcPGhMQvyYhb" style="width: 13%; text-align: right" title="Derivative liability at beginning balance">39,543</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Issuances:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: justify">Embedded derivatives</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--IssuanceOfEmbeddedDerivatives_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_z1r5M90oYHjc" style="text-align: right" title="Derivative liability issuance">670,639</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Warrant derivatives</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DerivativeLiabilities_iI_c20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zezpIJ1H4nO8" style="text-align: right" title="Derivative liability warrant derivatives">72,973</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Extinguishments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Embedded derivatives</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ExtinguishmentsOfEmbeddedDerivatives_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zNfUOgnMicCc" style="text-align: right" title="Derivative liability extinguishments">(89,237</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: justify">Warrant derivatives</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ExtinguishmentsWarrantsDerivatives_iI_c20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zhhmUptnVGz9" style="text-align: right" title="Derivative liability warrant derivatives">(391,437</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Changes in fair value inputs and assumptions reflected in operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DerivativeGainOnDerivative_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zG8u69wk3nG3" style="border-bottom: Black 1pt solid; text-align: right" title="Changes in fair value inputs and assumptions reflected in operations">318,942</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Balances at end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zQyArkcYdXx4" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability at ending balance">621,423</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zp8GQ1oBUyUa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details - Derivative liabilities)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Schedule of derivative liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">The financings giving rise to derivative financial instruments</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Indexed Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Values</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Embedded derivative liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--IndexedSharesEmbeddedDerivatives_iI_c20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zHWkY5YVK106" style="width: 13%; text-align: right" title="Indexed Shares">5,188,200</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_z3dYNDHcF3Ea" style="width: 13%; text-align: right" title="Fair Values">621,423</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_ecustom--IndexedSharesEmbeddedDerivatives_iI_c20260430_zmFpxu6eol05" style="border-bottom: Black 2.5pt double; text-align: right" title="Indexed Shares">5,188,200</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20260430_zrFvPyMOvqPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Values">621,423</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">The financings giving rise to derivative financial instruments</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Indexed Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Values</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Embedded derivative liabilities</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98F_ecustom--IndexedSharesEmbeddedDerivatives_iI_c20251031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_znEYxBwNOJgj" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Indexed Shares">393,717</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20251031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zBDqccXX66yi" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Fair Values">39,543</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_ecustom--IndexedSharesEmbeddedDerivatives_iI_c20251031_z2khQCM16vV4" style="border-bottom: Black 2.5pt double; text-align: right" title="Indexed Shares">393,717</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20251031_z4ECFphkFJv4" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Values">39,543</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

5188200

621423

5188200

621423

393717

39543

393717

39543

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_zcNFgPYneHQa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details - Changes in the fair values of the derivative)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of changes in the fair values of the derivative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three months Ended</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Embedded derivative liability</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260201__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zYUawYLFcD0d" style="width: 13%; text-align: right" title="Derivative gain or loss on derivative, net">(8,644</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250201__20250430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zidnwTAX3wUd" style="width: 13%; text-align: right" title="Derivative gain or loss on derivative, net"> –</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Warrant derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260201__20260430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantDerivativeLiabilityMember_zaIYaUK4Q2me" style="border-bottom: Black 1pt solid; text-align: right" title="Derivative gain or loss on derivative, net">(121,506</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250201__20250430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantDerivativeLiabilityMember_zufY9xeiXCn6" style="border-bottom: Black 1pt solid; text-align: right" title="Derivative gain or loss on derivative, net">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total gain (loss)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260201__20260430_zImZEJAl25da" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative gain or loss on derivative, net">(130,150</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250201__20250430_zutzXv04t6q7" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative gain or loss on derivative, net">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Six months Ended</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Embedded derivative liability</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeGainLossOnDerivativeNet_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zlAbvUor8f4d" style="width: 13%; text-align: right" title="Derivative gain or loss on derivative, net">(478</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20241101__20250430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_z7S446vjAtPj" style="width: 13%; text-align: right" title="Derivative gain or loss on derivative, net"> –</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Warrant derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantDerivativeLiabilityMember_z4GE9lYXUDAi" style="border-bottom: Black 1pt solid; text-align: right" title="Derivative gain or loss on derivative, net">(318,464</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20241101__20250430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantDerivativeLiabilityMember_zDSOLQexfKI8" style="border-bottom: Black 1pt solid; text-align: right" title="Derivative gain or loss on derivative, net">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total gain (loss)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeGainLossOnDerivativeNet_c20251101__20260430_zeKDlMy1cxsa" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative gain or loss on derivative, net">(318,942</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20241101__20250430_zHCiWqsq8Jhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative gain or loss on derivative, net">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

-8644

-121506

-130150

-478

-318464

-318942

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zfaVtfROZDXb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details - range of inputs by valuation technique)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Schedule of range of inputs from Lattice Model</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Inception Dates Note </td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Period Ended April 30, 2026 </td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 62%; text-align: justify">Underlying price on valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_906_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260826__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zYuAZWGMYtqi" title="Underlying price on valuation date">0.33 - <span id="xdx_902_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260826__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zTrjG1xbotyc" title="Underlying price on valuation date">1.03</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">$<span id="xdx_90D_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zigDEwX8b42k" title="Underlying price on valuation date">0.33 - <span id="xdx_90E_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_z2wLPdeOWX33" title="Underlying price on valuation date">0.42</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Effective contractual conversion rates</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_903_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260826__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputConversionPriceMember_zDywsvl4lWi3" title="Underlying price on valuation date">0.20 - <span id="xdx_903_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260826__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputConversionPriceMember_z04OUWkvsah4" title="Underlying price on valuation date">0.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">$<span id="xdx_906_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputConversionPriceMember_zNP4YRSz5PX" title="Underlying price on valuation date">0.20 - <span id="xdx_90D_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uUSDPShares_c20260430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputConversionPriceMember_z83NZ1GFg3E8" title="Underlying price on valuation date">0.36</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Contractual term to maturity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uYear_c20260826__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zO3JOMd24n03" title="Underlying price on valuation date">0.49 - <span id="xdx_908_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uYear_c20260826__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zDznnGd2OPhh" title="Underlying price on valuation date">1.00 years</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uYear_c20260430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zzC9XNRRGKXf" title="Underlying price on valuation date">0.13 - <span id="xdx_90F_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uYear_c20260430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z9lh2rZadsF6" title="Underlying price on valuation date">0.70 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Market volatility:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260826__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zxjvwN8y5mOk" title="Underlying price on valuation date">20.47 - <span id="xdx_906_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260826__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z7KweNylikzj" title="Underlying price on valuation date">26.90%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zRnIkEJu5sF2" title="Underlying price on valuation date">21.73 - <span id="xdx_90B_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zVmm0vLUG4c7" title="Underlying price on valuation date">24.04%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Risk-adjusted interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260826__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zQ3l5OD3LQv6" title="Underlying price on valuation date">3.43 - <span id="xdx_901_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260826__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z7EePifxt2Ch" title="Underlying price on valuation date">4.06%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zIpU6CPzB5b2" title="Underlying price on valuation date">3.71 - <span id="xdx_902_eus-gaap--EmbeddedDerivativeLiabilityMeasurementInput_iI_pip0_uPure_c20260430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z1xaHP05ugma" title="Embedded derivative liability, measurement input">3.76%</td><td style="text-align: left"> </td></tr> </table> The detachable warrants issued with the convertible notes require derivative liability classification due to agreements containing a fundamental transaction clause which could require net cash settlement in certain situations. The warrant fair value was calculated using the Black-Scholes option pricing model using the following inputs: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Inception</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dates Note</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify">Underlying price on valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pip0_uUSDPShares_c20260826__us-gaap--ValuationTechniqueAxis__custom--IncomeApproachValuationTechniqueBlackScholesMember__us-gaap--MeasurementInputTypeAxis__custom--UnderlyingPriceOnValuationDateMember_zBYOwQe8t333">0.60</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Effective contractual conversion rates</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pip0_uUSDPShares_c20260826__us-gaap--ValuationTechniqueAxis__custom--IncomeApproachValuationTechniqueBlackScholesMember__us-gaap--MeasurementInputTypeAxis__custom--EffectiveContractualConversionRatesMember_zvLn18MxyTfe">0.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Contractual term to maturity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pip0_uYear_c20260826__us-gaap--ValuationTechniqueAxis__custom--IncomeApproachValuationTechniqueBlackScholesMember__us-gaap--MeasurementInputTypeAxis__custom--ContractualTermToMaturityMember_zleEIB9fbjM8">5.00 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Market volatility:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pip0_uPure_c20260826__us-gaap--ValuationTechniqueAxis__custom--IncomeApproachValuationTechniqueBlackScholesMember__us-gaap--MeasurementInputTypeAxis__custom--MarketVolatilityMember_zmgLEtCQno6">23.36%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Risk-adjusted interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pip0_uPure_c20260826__us-gaap--ValuationTechniqueAxis__custom--IncomeApproachValuationTechniqueBlackScholesMember__us-gaap--MeasurementInputTypeAxis__custom--RiskAdjustedInterestRateMember_zWuABeeT5D4i" title="Warrants and rights outstanding, measurement input">3.72%</td><td style="text-align: left"> </td></tr> </table>

0.33

1.03

0.33

0.42

0.20

0.88

0.20

0.36

0.49

1.00

0.13

0.70

20.47

26.90

21.73

24.04

3.43

4.06

3.71

3.76

0.60

0.50

5.00

23.36

3.72

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zyaW49Ksxsya" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details - Changes in fair value inputs)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of changes in fair value inputs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify">Balances at beginning of period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zcPGhMQvyYhb" style="width: 13%; text-align: right" title="Derivative liability at beginning balance">39,543</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Issuances:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: justify">Embedded derivatives</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--IssuanceOfEmbeddedDerivatives_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_z1r5M90oYHjc" style="text-align: right" title="Derivative liability issuance">670,639</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Warrant derivatives</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DerivativeLiabilities_iI_c20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zezpIJ1H4nO8" style="text-align: right" title="Derivative liability warrant derivatives">72,973</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Extinguishments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Embedded derivatives</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ExtinguishmentsOfEmbeddedDerivatives_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zNfUOgnMicCc" style="text-align: right" title="Derivative liability extinguishments">(89,237</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: justify">Warrant derivatives</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ExtinguishmentsWarrantsDerivatives_iI_c20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zhhmUptnVGz9" style="text-align: right" title="Derivative liability warrant derivatives">(391,437</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Changes in fair value inputs and assumptions reflected in operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DerivativeGainOnDerivative_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zG8u69wk3nG3" style="border-bottom: Black 1pt solid; text-align: right" title="Changes in fair value inputs and assumptions reflected in operations">318,942</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Balances at end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20251101__20260430__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--EmbeddedDerivativeFinancialInstrumentsMember_zQyArkcYdXx4" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability at ending balance">621,423</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

39543

670639

72973

-89237 -391437

318942

621423

NOTE 8: STOCK OPTIONS On August 19, 2025, the Company adopted the Helio Corporation 2025 Equity Incentive Plan (the “2025 Plan”), which was also approved by the Company’s stockholders on August 19, 2025. The 2025 Plan is intended to assist the Company in recruiting and retaining employees, officers, directors, and consultants, and to provide incentives tied to increases in the value of the Company’s equity. Unless terminated earlier by the Board, the 2025 Plan will terminate on August 19, 2035, and no awards may be granted after that date. The 2025 Equity Plan limits the shares of common stock authorized to be awarded as stock awards to <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20260430__us-gaap--PlanNameAxis__custom--EquityPlanMember_zXkAnOn5oVZ8" title="Shares of common stock authorized"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20251031__us-gaap--PlanNameAxis__custom--EquityPlanMember_z0tFLVvCMBJa" title="Shares of common stock authorized">2,382,352 shares as of April 30, 2026 and October 31, 2025, respectively. Employees are provided stock options vesting over a period of four years with a one year cliff. After one year, <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_dp_c20251101__20260430__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityPlanMember_zenM4fmPyZCi" title="Percentage of vested">25% of the award size vests followed by 1/48th of the award size for each month thereafter. On a case-by-case basis, options have been granted outright with no vest period. Due to the change-in-control transaction described in Note 1, there was a recapitalization for which the Company’s stock options were adjusted for the new capital structure. The Company adjusted each of the granted options a 0.612 factor. During the three and six months ended April 30, 2026 and 2025, there were no stock options granted. <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z3caC5zpARqh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS (Details - Stock options granted)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Schedule of stock options granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price ($)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Term (Three months)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold">Three and six months ended April 30, 2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%">Balance as of October 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20241101__20250131_zkgE0l8y8Ezk" style="width: 11%; text-align: right" title="Number of shares at beginning balance">1,422,307</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20241101__20250131_zwI12EpoZgm8" style="width: 11%; text-align: right" title="Weighted average exercise price at beginning balance">0.09</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20231101__20241031_zBCh4FVaVW9j" title="Weighted average remaining contractual term">7.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20241101__20250131_zrynahImUdPb" style="width: 11%; text-align: right" title="Aggregate intrinsic value at beginning balance">6,980,951</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20241101__20250131_ztpPjZC8rXxi" style="text-align: right" title="Number of shares issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20241101__20250131_znOnqBCk4Vu5" style="text-align: right" title="Weighted average exercise price issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGrantDateIntrinsicValue_d0_c20241101__20250131_zbewfoHBsH8a" style="text-align: right" title="Aggregate intrinsic value issued">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20241101__20250131_znUxuM10C3G3" style="text-align: right" title="Number of shares canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20241101__20250131_zHqcvRhEFd27" style="text-align: right" title="Weighted average exercise price canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureInPeriodTotalIntrinsicValue_d0_c20241101__20250131_z5cfUu7BWs36" style="text-align: right" title="Aggregate intrinsic value canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20241101__20250131_z8lkhgIYEte6" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20241101__20250131_zcZItrQwamz8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20241101__20250131_zInJTEN79x3d" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance as of January 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20250201__20250430_zYe811WRMjef" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares at beginning balance">1,422,307</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20250201__20250430_zeR4JGNUObP6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price at beginning balance">0.09</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20241101__20250131_zheQhXrFgvR2" title="Weighted average remaining contractual term">6.77</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20250201__20250430_zzk7FWVkQhn4" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value at beginning balance">6,980,951</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20250201__20250430_zNFn2vDwKwx9" style="text-align: right" title="Number of shares issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20250201__20250430_zPY6ioWdcZF8" style="text-align: right" title="Weighted average exercise price issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGrantDateIntrinsicValue_d0_c20250201__20250430_zXtrmQ4FAtHc" style="text-align: right" title="Aggregate intrinsic value issued">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20250201__20250430_zr1G9L9zEtAk" style="text-align: right" title="Number of shares canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20250201__20250430_zIX1Z7SDOrDh" style="text-align: right" title="Weighted average exercise price canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureInPeriodTotalIntrinsicValue_d0_c20250201__20250430_zi48AbZ5KHse" style="text-align: right" title="Aggregate intrinsic value canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20250201__20250430_zyKYtgNdPlw" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20250201__20250430_zz2Gsdi3gs81" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20250201__20250430_zzRUL7YTw2jh" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance as of April 30, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20250201__20250430_zf9MRmPatm06" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares at ending balance">1,422,307</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20250201__20250430_z8RA1L3Deuk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price at ending balance">0.09</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250201__20250430_z3hAHBOCrT8i" title="Weighted average remaining contractual term">6.52</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20250201__20250430_zpT3enc6StYd" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value at ending balance">6,980,951</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Three and six months ended April 30, 2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Balance as of October 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20251101__20260131_zikO2KPFksTf" style="text-align: right" title="Number of shares at beginning">1,750,971</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20251101__20260131_zjcJnR7m1Vrh" style="text-align: right" title="Weighted average exercise price at beginning balance">0.43</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20241101__20251031_ztUqxY9QDGEj" title="Weighted average remaining contractual term">6.73</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20251101__20260131_zwtsetFobR5j" style="text-align: right" title="Aggregate intrinsic value at beginning balance">438,197</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20251101__20260131_zkRgkxIQEOqg" style="text-align: right" title="Number of shares issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20251101__20260131_zEj4EUEGUcuk" style="text-align: right" title="Weighted average exercise price issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGrantDateIntrinsicValue_d0_c20251101__20260131_zYk7rndYuOul" style="text-align: right" title="Aggregate intrinsic value issued">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20251101__20260131_zDIU3b3d65jb" style="text-align: right" title="Number of shares canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20251101__20260131_z5sF1TruXTRh" style="text-align: right" title="Weighted average exercise price canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureInPeriodTotalIntrinsicValue_d0_c20251101__20260131_zjGCgsUMISa" style="text-align: right" title="Aggregate intrinsic value canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20251101__20260131_zb1Rz47SBLHb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20251101__20260131_zCiOlfUACfdj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20251101__20260131_zBOEGZcHagZh" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance as of January 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260201__20260430_ztW2zitV5P1d" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares at beginning balance">1,750,971</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260201__20260430_z0uNqUxA5Tdk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price at beginning balance">0.43</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20251101__20260131_zsjPCEYGxWXa" title="Weighted average remaining contractual term">6.48</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20260201__20260430_zitiHmqr7bgl" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value at beginning balance">1,618,854</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20260201__20260430_znoFL47wzQI8" style="text-align: right" title="Number of shares issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20260201__20260430_z1Kri8ZRCOWj" style="text-align: right" title="Weighted average exercise price issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGrantDateIntrinsicValue_d0_c20260201__20260430_zBMGkDU10qkg" style="text-align: right" title="Aggregate intrinsic value issued">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20260201__20260430_z2d0Gs7zIoo2" style="text-align: right" title="Number of shares canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20260201__20260430_zNrtXipWtmx6" style="text-align: right" title="Weighted average exercise price canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureInPeriodTotalIntrinsicValue_d0_c20260201__20260430_zuavYUveEtd" style="text-align: right" title="Aggregate intrinsic value canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260201__20260430_zVd4acjZdEGc" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares exercised">52,604</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20260201__20260430_zv0rRUWTKpGg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price exercised">0.09</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20260201__20260430_zu7VAsaadL5h" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance as of April 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260201__20260430_zWeIlr42K8j4" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares at ending balance">1,698,367</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260201__20260430_zMxqZz7AULVg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price at ending balance">0.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260201__20260430_zFDrTWnf6Sob" title="Weighted average remaining contractual term">6.23</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20260201__20260430_zWUHe0Akcp28" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value at ending balance">3,298,610</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable as of April 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260430_zEEviE6hYUe1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares Exercisable">1,615,129</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260430_z5OzyabQVsXb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares Exercisable per shares">0.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260201__20260430_zjC7hKRcUni5" title="Weighted average remaining contractual term Exercisable">6.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20260430_zhmW8JZSr2nd" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value Exercisable">3,227,960</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Stock-based compensation from stock awards for the six months ended April 30, 2026 and 2025 was $59,381 and $87,754, respectively. Stock-based compensation from stock awards for the three months ended April 30, 2026 and 2025 was $26,997 and $41,257, respectively. As of April 30, 2026 and October 31, 2025, there remained $51,600 and $110,981 of unrecognized stock-based compensation from stock option awards, respectively. As of April 30, 2026, there were 1,615,129 shares of common stock related to stock option grants that were vested and 83,238 stock option grants that were unvested.

2382352

0.25

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z3caC5zpARqh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS (Details - Stock options granted)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Schedule of stock options granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price ($)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Term (Three months)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold">Three and six months ended April 30, 2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%">Balance as of October 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20241101__20250131_zkgE0l8y8Ezk" style="width: 11%; text-align: right" title="Number of shares at beginning balance">1,422,307</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20241101__20250131_zwI12EpoZgm8" style="width: 11%; text-align: right" title="Weighted average exercise price at beginning balance">0.09</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20231101__20241031_zBCh4FVaVW9j" title="Weighted average remaining contractual term">7.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20241101__20250131_zrynahImUdPb" style="width: 11%; text-align: right" title="Aggregate intrinsic value at beginning balance">6,980,951</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20241101__20250131_ztpPjZC8rXxi" style="text-align: right" title="Number of shares issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20241101__20250131_znOnqBCk4Vu5" style="text-align: right" title="Weighted average exercise price issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGrantDateIntrinsicValue_d0_c20241101__20250131_zbewfoHBsH8a" style="text-align: right" title="Aggregate intrinsic value issued">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20241101__20250131_znUxuM10C3G3" style="text-align: right" title="Number of shares canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20241101__20250131_zHqcvRhEFd27" style="text-align: right" title="Weighted average exercise price canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureInPeriodTotalIntrinsicValue_d0_c20241101__20250131_z5cfUu7BWs36" style="text-align: right" title="Aggregate intrinsic value canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20241101__20250131_z8lkhgIYEte6" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20241101__20250131_zcZItrQwamz8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20241101__20250131_zInJTEN79x3d" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance as of January 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20250201__20250430_zYe811WRMjef" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares at beginning balance">1,422,307</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20250201__20250430_zeR4JGNUObP6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price at beginning balance">0.09</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20241101__20250131_zheQhXrFgvR2" title="Weighted average remaining contractual term">6.77</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20250201__20250430_zzk7FWVkQhn4" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value at beginning balance">6,980,951</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20250201__20250430_zNFn2vDwKwx9" style="text-align: right" title="Number of shares issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20250201__20250430_zPY6ioWdcZF8" style="text-align: right" title="Weighted average exercise price issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGrantDateIntrinsicValue_d0_c20250201__20250430_zXtrmQ4FAtHc" style="text-align: right" title="Aggregate intrinsic value issued">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20250201__20250430_zr1G9L9zEtAk" style="text-align: right" title="Number of shares canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20250201__20250430_zIX1Z7SDOrDh" style="text-align: right" title="Weighted average exercise price canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureInPeriodTotalIntrinsicValue_d0_c20250201__20250430_zi48AbZ5KHse" style="text-align: right" title="Aggregate intrinsic value canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20250201__20250430_zyKYtgNdPlw" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20250201__20250430_zz2Gsdi3gs81" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20250201__20250430_zzRUL7YTw2jh" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance as of April 30, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20250201__20250430_zf9MRmPatm06" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares at ending balance">1,422,307</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20250201__20250430_z8RA1L3Deuk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price at ending balance">0.09</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250201__20250430_z3hAHBOCrT8i" title="Weighted average remaining contractual term">6.52</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20250201__20250430_zpT3enc6StYd" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value at ending balance">6,980,951</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Three and six months ended April 30, 2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Balance as of October 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20251101__20260131_zikO2KPFksTf" style="text-align: right" title="Number of shares at beginning">1,750,971</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20251101__20260131_zjcJnR7m1Vrh" style="text-align: right" title="Weighted average exercise price at beginning balance">0.43</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20241101__20251031_ztUqxY9QDGEj" title="Weighted average remaining contractual term">6.73</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20251101__20260131_zwtsetFobR5j" style="text-align: right" title="Aggregate intrinsic value at beginning balance">438,197</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20251101__20260131_zkRgkxIQEOqg" style="text-align: right" title="Number of shares issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20251101__20260131_zEj4EUEGUcuk" style="text-align: right" title="Weighted average exercise price issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGrantDateIntrinsicValue_d0_c20251101__20260131_zYk7rndYuOul" style="text-align: right" title="Aggregate intrinsic value issued">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20251101__20260131_zDIU3b3d65jb" style="text-align: right" title="Number of shares canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20251101__20260131_z5sF1TruXTRh" style="text-align: right" title="Weighted average exercise price canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureInPeriodTotalIntrinsicValue_d0_c20251101__20260131_zjGCgsUMISa" style="text-align: right" title="Aggregate intrinsic value canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20251101__20260131_zb1Rz47SBLHb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20251101__20260131_zCiOlfUACfdj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20251101__20260131_zBOEGZcHagZh" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance as of January 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260201__20260430_ztW2zitV5P1d" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares at beginning balance">1,750,971</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260201__20260430_z0uNqUxA5Tdk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price at beginning balance">0.43</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20251101__20260131_zsjPCEYGxWXa" title="Weighted average remaining contractual term">6.48</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20260201__20260430_zitiHmqr7bgl" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value at beginning balance">1,618,854</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20260201__20260430_znoFL47wzQI8" style="text-align: right" title="Number of shares issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20260201__20260430_z1Kri8ZRCOWj" style="text-align: right" title="Weighted average exercise price issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGrantDateIntrinsicValue_d0_c20260201__20260430_zBMGkDU10qkg" style="text-align: right" title="Aggregate intrinsic value issued">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20260201__20260430_z2d0Gs7zIoo2" style="text-align: right" title="Number of shares canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20260201__20260430_zNrtXipWtmx6" style="text-align: right" title="Weighted average exercise price canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureInPeriodTotalIntrinsicValue_d0_c20260201__20260430_zuavYUveEtd" style="text-align: right" title="Aggregate intrinsic value canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260201__20260430_zVd4acjZdEGc" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares exercised">52,604</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20260201__20260430_zv0rRUWTKpGg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price exercised">0.09</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20260201__20260430_zu7VAsaadL5h" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance as of April 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260201__20260430_zWeIlr42K8j4" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares at ending balance">1,698,367</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260201__20260430_zMxqZz7AULVg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price at ending balance">0.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260201__20260430_zFDrTWnf6Sob" title="Weighted average remaining contractual term">6.23</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20260201__20260430_zWUHe0Akcp28" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value at ending balance">3,298,610</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable as of April 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260430_zEEviE6hYUe1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares Exercisable">1,615,129</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260430_z5OzyabQVsXb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares Exercisable per shares">0.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260201__20260430_zjC7hKRcUni5" title="Weighted average remaining contractual term Exercisable">6.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20260430_zhmW8JZSr2nd" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value Exercisable">3,227,960</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1422307

0.09

P7Y7D

6980951

1422307

0.09

P6Y9M7D

6980951

1422307

0.09

P6Y6M7D

6980951

1750971

0.43

P6Y8M23D

438197

1750971

0.43

P6Y5M23D

1618854

52604

0.09

1698367

0.44

P6Y2M23D

3298610

1615129

0.45

P6Y2M4D

3227960

59381

87754

26997

41257

51600

110981

1615129

83238

NOTE 9: LEASES The Company leases its manufacturing facility and it is classified as an operating lease. The Company recognized right of use assets and lease liability pursuant to these leases. Leases with an initial term of 12 months or less or leases that are immaterial are not included on the condensed consolidated balance sheets. The lease liability was calculated at the commencement date of the lease by discounting the future payments using the Company’s incremental borrowing rate of 10%. The lease for the manufacturing facility commenced on June 1, 2022, and has a term of five years. For the first twelve months the monthly lease payments were $36,000. The monthly lease payments are subject to an annual increase of 3%. Right-of-use lease asset is summarized below: <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--LeaseCostTableTextBlock_zf91DSf70pk5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Right of use lease asset and operating lease liability)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Schedule of right-of-use lease asset and operating lease liability </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Manufacturing lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization_iI_c20260430__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_zn5RVOQoSB3e" style="width: 13%; text-align: right" title="Manufacturing lease">1,788,571</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization_iI_c20251031__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_zj26AcpbzE0b" style="width: 13%; text-align: right">1,788,571</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortizations_iNI_di_c20260430__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_z9sDdm5bpRQ2" style="border-bottom: Black 1pt solid; text-align: right" title="Less: accumulated amortization">(1,389,270</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortizations_iNI_di_c20251031__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_z2tGP8JN6Twj" style="border-bottom: Black 1pt solid; text-align: right">(1,222,210</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Right-of-use lease asset, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20260430__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_zI8jR4nYYc83" style="border-bottom: Black 2.5pt double; text-align: right">399,301</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20251031__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_zc9FYHdRQod2" style="border-bottom: Black 2.5pt double; text-align: right">566,361</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Operating lease liability is summarized below: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Manufacturing lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseLiability_iI_c20260430__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zcCK8HA75GSe" style="width: 13%; text-align: right" title="Manufacturing lease">496,077</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseLiability_iI_c20251031__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zffYNZWBb64i" style="width: 13%; text-align: right" title="Manufacturing lease">701,275</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_c20260430__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zzE56xny7HI8" style="border-bottom: Black 1pt solid; text-align: right" title="Less: current portion">(455,892</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_c20251031__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zAdriC1V64Lj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: current portion">(477,956</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20260430__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zhdwdEk7vw4k" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">40,185</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20251031__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zOwDqOTbLXe9" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">223,319</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Future minimum lease payments required under this operating lease on an undiscounted cash flow basis as of April 30, 2026 were as follows: <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z3HOPcW717y5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Future minimum lease payments)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20260430_zXwwQPfA1Hj1" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_z6VA4h62zj48" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify">Remainder of 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">241,928</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zRufh9sWrRqk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">2027</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">283,626</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zx1yoZPGtmp5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Total future minimum lease payments</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">525,554</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zcyoIVGvajgc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less imputed interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(29,477</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_z8SLk4nAgxpi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total operating lease liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">496,077</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Company recognized rent expense pursuant to this lease on the straight-line basis in accordance with the guidance in ASC 842. The Company recognized rent expense of $208,670 and $200,038 for the six months ended April 30, 2026 and 2025, related to this lease, The Company recognized rent expense of $89,430 and $100,019 for the three months ended April 30, 2026 and 2025, related to this lease, which is included within facilities expense on the condensed consolidated statements of operations.

0.10

36000

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--LeaseCostTableTextBlock_zf91DSf70pk5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Right of use lease asset and operating lease liability)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Schedule of right-of-use lease asset and operating lease liability </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Manufacturing lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization_iI_c20260430__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_zn5RVOQoSB3e" style="width: 13%; text-align: right" title="Manufacturing lease">1,788,571</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization_iI_c20251031__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_zj26AcpbzE0b" style="width: 13%; text-align: right">1,788,571</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortizations_iNI_di_c20260430__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_z9sDdm5bpRQ2" style="border-bottom: Black 1pt solid; text-align: right" title="Less: accumulated amortization">(1,389,270</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortizations_iNI_di_c20251031__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_z2tGP8JN6Twj" style="border-bottom: Black 1pt solid; text-align: right">(1,222,210</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Right-of-use lease asset, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20260430__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_zI8jR4nYYc83" style="border-bottom: Black 2.5pt double; text-align: right">399,301</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20251031__us-gaap--NatureOfExpenseAxis__custom--RightOfUseLeaseAssetMember_zc9FYHdRQod2" style="border-bottom: Black 2.5pt double; text-align: right">566,361</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Operating lease liability is summarized below: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">April 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">October 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Manufacturing lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseLiability_iI_c20260430__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zcCK8HA75GSe" style="width: 13%; text-align: right" title="Manufacturing lease">496,077</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseLiability_iI_c20251031__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zffYNZWBb64i" style="width: 13%; text-align: right" title="Manufacturing lease">701,275</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_c20260430__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zzE56xny7HI8" style="border-bottom: Black 1pt solid; text-align: right" title="Less: current portion">(455,892</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_c20251031__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zAdriC1V64Lj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: current portion">(477,956</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20260430__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zhdwdEk7vw4k" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">40,185</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20251031__us-gaap--NatureOfExpenseAxis__custom--OperatingLeaseLiabilityMember_zOwDqOTbLXe9" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">223,319</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1788571 1788571 1389270 1222210

399301

566361

496077

701275

455892

477956

40185

223319

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z3HOPcW717y5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Future minimum lease payments)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20260430_zXwwQPfA1Hj1" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_z6VA4h62zj48" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify">Remainder of 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">241,928</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zRufh9sWrRqk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">2027</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">283,626</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zx1yoZPGtmp5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Total future minimum lease payments</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">525,554</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zcyoIVGvajgc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less imputed interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(29,477</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_z8SLk4nAgxpi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total operating lease liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">496,077</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

241928

283626

525554

29477

496077

208670

200038

89430

100019

NOTE 10: COMMITMENTS AND CONTINGENCIES Legal Proceedings The Company is not presently a party to any legal proceedings, the resolution of which the Company believes would have a material adverse effect on its business, financial condition, operating results, or cash flows. However, legal proceedings are subject to inherent uncertainties, and an unfavorable outcome could include monetary damages, and excessive verdicts can result from litigation, and as such, could result in a material adverse impact on its business, financial position, results of operations, and/or cash flows.

NOTE 11: CLIENT CONCENTRATIONS Four customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--FourCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_ztucle1LPp5i">96% of the Company’s outstanding receivables on April 30, 2026 and four customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--FourCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxHdb7I7WLlb">99% of the Company’s outstanding receivables on October 31, 2025. The table below summarizes the revenue concentrations by customer as of April 30, 2026, and October 31, 2025: <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zW8JbvcpjOQ8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CLIENT CONCENTRATIONS (Details - Accounts receivable concentration by customer)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of accounts receivable concentrations by customer</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenue Concentration</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">April 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">October 31</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Company</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zyZCIvSz8Qoh" title="Concentration risk, percentage">39%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zuckWFUndj8c" title="Concentration risk, percentage">45%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2lwkQWThwP9" title="Concentration risk, percentage">26%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zfTCHJxfvDqc" title="Concentration risk, percentage">31%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgA4dI12xZB1" title="Concentration risk, percentage">22%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_ziRmEuxxLi5e" title="Concentration risk, percentage">17%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">D</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zmTPfGDfmhk3" title="Concentration risk, percentage">9%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zunK9HCxjWId" title="Concentration risk, percentage">6%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--TotalCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbdB28yboHXk" title="Concentration risk, percentage">96%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--TotalCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMmJBYNuMNu8" title="Concentration risk, percentage">99%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> For the three months ended April 30, 2026 and 2025, the Company’s revenue was concentrated amongst five and nine customers, respectively. For the three months ended April 30, 2026, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20260201__20260430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--GovernmentSourcesMember_zROnOtXRngMg" title="Concentration risk, percentage">93% of all revenue was obtained from government sources either as a direct contractor or subcontractor with the remaining <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20260201__20260430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--PrivateCustomerMember_z9Wmz6peeNJ5" title="Concentration risk, percentage">7% from a private customer. For the three months ended April 30, 2025, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20250201__20250430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--GovernmentSourcesMember_zOQQx7Qall7k" title="Concentration risk, percentage">57% of all revenue was obtained from government sources either as a direct contractor or subcontractor, with the remaining <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20250201__20250430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--PrivateCustomerMember_zYJiNmeb9ru" title="Concentration risk, percentage">43% of revenue from private customers. For the six months ended April 30, 2026 and 2025, the Company’s revenue was concentrated amongst five and nine customers, respectively. For the six months ended April 30, 2026, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--GovernmentSourcesMember_zl5EiSydEGPk" title="Concentration risk, percentage">84% of all revenue was obtained from government sources either as a direct contractor or subcontractor with the remaining <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--PrivateCustomerMember_zEeN5G10lK5h" title="Concentration risk, percentage">16% from a private customer. For the six months ended April 30, 2025, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20250430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--GovernmentSourcesMember_zMXOluiWCSK" title="Concentration risk, percentage">67% of all revenue was obtained from government sources either as a direct contractor or subcontractor, with the remaining <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20250430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--PrivateCustomerMember_zE2L0gVCNg3b" title="Concentration risk, percentage">33% of revenue from private customers.

0.96

0.99

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zW8JbvcpjOQ8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CLIENT CONCENTRATIONS (Details - Accounts receivable concentration by customer)"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Schedule of accounts receivable concentrations by customer</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenue Concentration</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">April 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">October 31</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Company</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zyZCIvSz8Qoh" title="Concentration risk, percentage">39%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zuckWFUndj8c" title="Concentration risk, percentage">45%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2lwkQWThwP9" title="Concentration risk, percentage">26%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zfTCHJxfvDqc" title="Concentration risk, percentage">31%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgA4dI12xZB1" title="Concentration risk, percentage">22%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_ziRmEuxxLi5e" title="Concentration risk, percentage">17%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">D</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zmTPfGDfmhk3" title="Concentration risk, percentage">9%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zunK9HCxjWId" title="Concentration risk, percentage">6%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20251101__20260430__srt--MajorCustomersAxis__custom--TotalCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbdB28yboHXk" title="Concentration risk, percentage">96%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20241101__20251031__srt--MajorCustomersAxis__custom--TotalCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMmJBYNuMNu8" title="Concentration risk, percentage">99%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

0.39

0.45

0.26

0.31

0.22

0.17

0.09

0.06

0.96

0.99

five

nine

0.93

0.07

0.57

0.43

five

nine

0.84

0.16

0.67

0.33

NOTE 12: SEGMENT INFORMATION The Company conducts its business activities and reports financial results as <span id="xdx_905_eus-gaap--NumberOfReportableSegments_dxL_uInteger_c20251101__20260430__us-gaap--StatementBusinessSegmentsAxis__custom--BusinessSegmentMember_zUFWHNw5lpdc" title="Number of reportable segments::XDX::1">one business segment. The presentation of financial results as one reportable segment is consistent with the way the Company operates its business and is consistent with the manner in which the Chief Operating Decision Maker (“CODM”) evaluates performance and makes resource and operating decisions for the business. The Company’s CODM is the Chief Executive Officer. Furthermore, the Company notes that monitoring financial results as one reportable segment helps the CODM manage costs on a consolidated basis, consistent with the integrated nature of the operations. The CODM uses net loss, as reported on the Condensed Consolidated Statements of Operations, in evaluating the performance of the Company and determining how to allocate resources of the Company as a whole. As the CODM evaluates performance on a consolidated basis, all required financial segment information is included in the condensed consolidated financial statements.

NOTE 13: EQUITY Common Stock During the three months ending April 30, 2026, the Company issued the following common stock for services: 321,000 shares to consultants for services performed in lieu of cash totaling $33,540; 50,000 shares to its CFO as compensation totaling $31,892; and the Company issued 150,000 shares to Board members as compensation totaling $209,500. During the three months ending January 31, 2026, the Company issued 3,000,000 shares to its CEO as compensation totaling $1,500,000 and 1,262,000 shares to a consultants in lieu of cash totaling $631,600. On March 12, 2026, a convertible note holder received 263,198 shares of common stock in exchange for a cashless exercise of 300,000 warrants. Series A Preferred Stock On April 17, 2026, the Company designated 1,500,000 shares of Series A Convertible Preferred Stock ("Series A Preferred Stock"), par value $0.0001 per share, pursuant to a Certificate of Designation filed with the State of Florida. Each share of Series A Preferred Stock has a stated value of $1.00 per share. The Series A Preferred Stock ranks senior to the Company’s common stock with respect to dividend rights and distributions upon liquidation, dissolution, or winding up of the Company. Holders are entitled to cumulative dividends at an annual rate of 10% of the stated value, payable upon redemption, liquidation, or conversion. Upon the occurrence of certain events of default, the dividend rate increases to 22%. In the event of liquidation, dissolution, winding up, or a deemed liquidation event, holders of Series A Preferred Stock are entitled to receive, prior to any distribution to holders of common stock, an amount equal to the stated value of the shares plus accrued and unpaid dividends and any applicable adjustment amounts as defined in the Certificate of Designation. The Company may redeem the Series A Preferred Stock during specified redemption periods at amounts ranging from <span id="xdx_904_eus-gaap--PreferredStockDividendRatePercentage_dp_c20260416__20260417__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--RangeAxis__srt--MinimumMember_z2BEATulvGtb" title="Dividends annual rate">110% to <span id="xdx_905_eus-gaap--PreferredStockDividendRatePercentage_dp_c20260416__20260417__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--RangeAxis__srt--MaximumMember_zPE8lkv7bha4" title="Dividends annual rate">123% of the stated value, subject to the terms of the Certificate of Designation. In addition, beginning twelve months after issuance, or upon certain events of default, the Company may be required to redeem the outstanding shares for cash. Beginning 180 days after issuance, holders may convert the Series A Preferred Stock into shares of the Company’s common stock. The conversion price is variable and is generally equal to 65% of the lowest trading price of the Company’s common stock during the ten trading days preceding the conversion date, subject to adjustment provisions contained in the Certificate of Designation. On February 6, 2026, the Company sold <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260203__20260206__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zwQpsobr8Su3" title="Number of shares sold">15 shares of Series A Convertible Preferred Stock for $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20260203__20260206__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zPn0jFwfpaVj" title="Number of value sold">15,000. The shares were simultaneously converted into <span id="xdx_902_eus-gaap--ConversionOfStockSharesConverted1_c20260203__20260206__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zzHrwdRXssX3" title="Number of shares converted">12,510 shares of common stock. As of April 30, 2026, there are <span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20260206__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zRv6l1fxRyLf" title="Preferred stock outstanding">no shares of Series A Convertible Preferred Stock outstanding. Series D Preferred Stock On April 30, 2026, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20251101__20260430__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zWMgcBRmGqLh" title="Number of shares issued">250,000 shares of Convertible Preferred Stock to an investor for aggregate cash proceeds of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20251101__20260430__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zTqMWTcAcWP1" title="Number of value issued">100,000, or $0.40 per share. The shares were issued pursuant to a Securities Purchase Agreement dated April 30, 2026. The Convertible Preferred Stock carries a cumulative annual dividend equal to 10% of the face value of the preferred shares held by the investor. Dividends accrue annually and are payable in accordance with the terms of the agreement. The Company evaluated the terms of the Convertible Preferred Stock under ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging. Based on management’s analysis, the Convertible Preferred Stock was classified as permanent equity as of April 30, 2026. As of April 30, 2026, 250,000 shares of Convertible Preferred Stock were issued and outstanding with an aggregate carrying value of $<span id="xdx_904_eus-gaap--ConversionOfStockAmountIssued1_c20251101__20260430__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zoGGMNvdkUrc" title="Aggregate carrying value">100,000 and an aggregate stated value of $<span id="xdx_90B_eus-gaap--ConversionOfStockAmountConverted1_c20251101__20260430__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zwuesawV4y85" title="Aggregate stated value">100,000.

321000

33540

50000

31892

150000

209500

3000000

1500000

1262000

631600

263198

300000

1500000

0.0001

1.00

0.10

0.22

1.10

1.23

15000

12510

250000

100000

0.40

250000

100000

NOTE 14: SUBSEQUENT EVENTS In preparing these condensed consolidated financial statements, management has evaluated events and transactions for potential recognition or disclosure through the date the financial statements were issued. Such events or transactions are described below as of the date these unaudited condensed consolidated financial statements were issued. The following subsequent events occurred after April 30, 2026, and prior to the filing of this Quarterly Report on Form 10-Q. Private Placement Memorandum Between May 1st and May 11th, 2026, the Company raised any additional $284,800 in proceeds in exchange for 149,409 shares of common stock in connection with the April 2026 Private Placement Memorandum. Series A Convertible Preferred Stock On May 8, 2026, the Company raised $175,000 through the sale of Series A Convertible Preferred Stock. Series B Convertible Preferred Stock On May 29, 2026, the Company raised $175,000 through the sale of Series B Convertible Preferred Stock. Convertible Note Payable Amendment The Company has a convertible note payable agreement for $250,000 dated July 31, 2024. This note was considered in default as of April 30, 2025. On June 13, 2026, the Company executed an agreement whereby the holder agreed not to pursue any default provisions in exchange for a payment plan and stock consideration. Upon execution of the agreement, the Company is obligated to pay the holder $20,000 and will pay monthly installments of $15,000 beginning July 15, 2026. Additionally, the Company agrees to issue 33, 000 shares of common stock to the holder.

false false false false As of October 31, 2025, these noteholders were considered related parties. As of April 30, 2026, these noteholders are no longer considered related parties and their balances have been reclassified to notes payable. Their notes are described in Note 4 – Notes Payable, Related Parties. On April 23, 2026, this note balance was transferred from a related party to a non-related party for no consideration.